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Resumo 
Atualmente existe um debate sobre “Scans Without Evidence for Dopaminergic Deficit" 
(SWEDD) de ser uma patologia independente ou um subtipo benigno da doença de 
Parkinson (DP).  
Neste estudo analisou-se a conectividade estrutural cerebral de 30 indivíduos saudáveis, 
29 doentes com SWEDD e 29 doentes com DP, utilizando diversos softwares 
especializados e a teoria dos grafos para caracterizar 96 regiões de interesse. Diferentes 
métricas de imagem e de conectividade foram obtidas a partir de dados de imagem em 
ponderação T1 e de tensor de difusão.  
Em relação aos dados demográficos dos grupos, observaram-se diferenças estatísticas 
na Unified Parkinson Disease Rating Scale entre os indivíduos saudáveis (Controlo) e os 
doentes com DP (p = 0,000), e com SWEDD (p = 0,000). Na comparação Controlo vs DP, 
várias diferenças foram observadas em relação às métricas de imagem e de 
conectividade, particularmente nos núcleos da base de ambos os hemisférios. No 
Controlo vs SWEDD, as regiões dos lobos frontal e parietal mostraram alterações nas 
métricas de conectividade, particularmente o giro marginal superior e o giro parietal 
superior de ambos os hemisférios. Na DP vs SWEDD, foram observadas alterações de 
métricas de imagem e de conectividade, particularmente no polo frontal e no córtex pré-
frontal anterior. Todos os resultados observados neste estudo estão de acordo com a 
literatura sobre mudanças observadas nas regiões relacionadas com as, mesolímbica 
mesocortical e nigroestriatal. Estes achados sugerem que o estudo da conectividade 
estrutural é um importante método para distinguir SWEDD e DP. 
 
Palavras-chave: Conectividade estrutural cerebral, Doença de Parkinson, Ressonância 
Magnética, Imagem por Tensor de Difusão, Imagem Ponderada em T1. 
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Abstract 
Currently, there is an ongoing controversy about Scans Without Evidence of 
Dopaminergic deficit (SWEDD) being a Parkinson’s Disease (PD) lookalike disease or a 
benign subtype of PD. 
In this study the brain structural connectivity of 30 healthy subjects, 29 patients with 
SWEDD and 29 patients with PD was analysed, using various specialized software and 
graph theory to characterize the structural connectivity of 96 regions of interest. Different 
imaging metrics and connectivities were obtained from diffusion tensor imaging and T1 
weighted data. 
With regard to group data, statistical differences in Unified Parkinson Disease Rating 
Scale (UPDRS) scores were observed between healthy subjects (Control) and PD 
(p=0.000) and SWEDD (p=0.000) patients. In comparing Control vs PD, several 
differences were observed regarding various imaging and connectivity metrics, particularly 
in the basal ganglia of both hemispheres. In comparing Control vs SWEDD, regions of the 
frontal and parietal lobes showed various connectivity metrics changes, particularly in the 
superior marginal gyrus and superior parietal gyrus of both hemispheres. In comparing 
SWEDD vs PD, various DTI-based imaging and connectivity metrics changes were 
observed, particularly in the frontal pole and rostral middle frontal gyrus. 
All results observed in this study are in agreement with the literature regarding observed 
changes in regions related to the nigrostriatal, mesocortical and mesolimbic pathways. 
These findings suggest that the study of SC is an important method in distinguishing 
between SWEDD and PD. 
 
Keywords: Structural Connectivity, Parkinson’s Disease, Magnetic Resonance Imaging, 
T1-w, Diffusion Tensor Imaging. 
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1. Introduction  
Since the twentieth century we have been witnessing the development of artificial 
neural networks, which, inspired by their biological counterparts, are enabling us to 
gain a deeper understanding of the workings of the brain. (1,2) Today, it is believed 
that the basis of information processing and mental representations lies in neural 
networks. 
Understanding the brain’s structural and functional organization is a daunting task, 
as described already in the first studies on the brain and most notably since the mid 
1990s when the complexity of the macroscopic behaviour of a system of interacting 
elements that combines statistics and arbitrariness with constancy became clear.(1–
3) 
The increasing accessibility and manageability of large and high-quality data sets on 
an extensive range of neural structures has led to an essential vision: different neural 
systems often share certain important values, which can be quantitatively considered 
and categorised by the same parameters.(2,3) In other words, we can see 
similarities in many complex organizations despite the complexity and differences in 
the details or their connections. 
In recent years, many scientific studies have been performed using small-world 
architectures.(2–4) This mathematical model has been used on brain networks in 
humans and other animals, and over a varied range of measures in space and time, 
to understand the structural and functional systems.(2–4) 
One of the most common neurodegenerative diseases and the most common form 
of Parkinsonism is Parkinson’s disease (PD).(5–7) This disease usually affects 
people over 50 years old. Usually, the manifestations of this disease are seen at the 
level of the gait and tremors (at this stage the patient has important impairments of 
the dopaminergic system).(6,8) Many studies have been conducted with a view to 
developing diagnostics and understanding the mechanism of this disease. One of 
the methods is neuroimaging, such as magnetic resonance imaging with the 
diffusion-weighted imaging (DWI) technique. This technique has been used for 
accessing the microstructure of the regions with parameter changes in diffusion 
parametric and connectivity levels.(8,9)  
The principal motivation for carrying out this research is to demonstrate the 
importance of the study of structural brain connectivity in patients with PD, 
Brain Connectivity Analysis of Parkinson's Disease Patients. 
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particularly by evaluating the differences in the structural brain connectivity between 
patients with PD, those with SWEDD and healthy individuals. A multimodal approach 
was adopted and graph theoretical analysis performed to demonstrate the potential 
of this method for studying the networks of the brain.  
In this thesis, the T1-weighted (T1-w) and DTI capabilities of the fully automated all-
in-one connectivity analysis toolbox Multimodal Imaging Brain Connectivity Analysis 
(MIBCA) were exploited. The software performs preprocessing, connectivity and 
graph theory analysis, and visualization of multimodal data such as anatomical MRI 
(aMRI), diffusion MRI (dMRI), functional MRI (fMRI) and positron emission 
tomography (PET). Here, MIBCA was applied to SWEDD and PD patients.  
The thesis is organized as follows: 
1. Theoretical concepts 
2. Materials and methods 
3. Results and discussion 
4. Limitations of this study 
5. Conclusions. 
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2. Theoretical concepts 
2.1 Parkinson’s Disease – Definition and diagnostic 
Since the detection and conception of the first definition of PD, there have been huge 
changes in the conceptualization of the disease.(5,6) One of the reasons is a better 
understanding of motor manifestations,(5) clear pathological definitions (6,7) and the 
availability of therapy that is as effective as a part of the diagnostic criteria.(7,9) In 
addition, our knowledge about this pathology has always been under constant 
development: for example, the identification of non-motor aspects, recognition of 
neurodegeneration symptoms and a better understanding of genetics and 
environmental factors.(6,7) With these improvements, clinicians and specialists in 
genetics, epidemiology, pathology and basic science have created their own 
definitions of disease,(5,7) all of them valid, but none representing the “truth”.(8)  
The International Parkinson and Movement Disorder Society (MDS) has created one 
“standard” definition.(8) Most clinicians would approve of the notion that this disease 
is diagnosed through a combination of clinical and pathological syndromes.(7,8) 
However, until now, the “real” definition of PD has not fully emerged.(9) 
PD is a neurodegenerative disease and the most common neurodegenerative cause 
of Parkinsonism (a combination of bradykinesia, rigidity and tremor).(5,6,8) It is 
considered a hallmark within the severe loss of dopaminergic projection neurons of 
the substantia nigra (SN).(6–8) Normally, this neurodegeneration consequence 
involves a loss of dopaminergic innervation in the striatum and is frequently 
accompanied by extensive extranigral pathology.(7,8) PD is more prevalent in 
subjects of advanced age, with the average age for onset of the disease being over 
50 years.(6) 
The aetiology is still unknown. However, it is known that there are environmental 
factors such as exposure to toxins that are associated with increased genetic 
predisposition of the individual and can promote the expression of this disease.(7–9) 
It can also occur as a result of many mutations in genes that are associated with the 
disease’s development.(7,8) 
The SN is divided anatomically and functionally into two distinct areas/regions.(9,10) 
The first region is the SN pars compacta (SNc) and is characterized by neuron 
projections to the globus pallidus, striatum, subthalamic nucleus, anterior thalamic 
nuclei and prefrontal cortex.(10) The second SN region is the SN pars reticulata 
Brain Connectivity Analysis of Parkinson's Disease Patients. 
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(SNr) and this region involves neuron projections to the ventral thalamic nuclei and 
prefrontal cortex and receives afferents from the striatum, external globus pallidus 
and subthalamic nucleus.(10) 
The damage to the SN is not uniform. Usually, this degeneration occurs in the caudal 
and lateral SN and the caudolateral sensorimotor putamen.(8,9) In PD, the motor 
symptoms appear as a consequence of preferential degeneration in the 
sensorimotor region.(7–9) 
Beyond the motor symptoms, this neurodegenerative pathology causes variable 
degrees of cognitive impairment in a high fraction of patients.(6,8) The occurrence of 
cognitive deficits in untreated, newly diagnosed patients has been described to be 
between 19 and 24 %.(6,7) The most commonly affected cognitive functions are 
attention/executive, episodic memory, visuospatial/visuoperceptual and 
hallucinations.(8,9) A higher risk exists of subsequently developing dementia in 
patients with mild cognitive impairment.(6,8) It is critical as well to mention that this 
pathology normally involves the whole brain.(9) 
2.1. Anatomy of the brain in Parkinson’s disease’ 
Anatomical structures undergo many alterations in PD, starting in the brainstem, 
following with subcortical regions and finishing in the cortex.(7,8) In this thesis it will 
be demonstrated and explained where the most common regions for such changes 
are in a subject with this pathology.  
 Mesencephalon: Regions that belong to the brainstem, located above and below 
the bulge of the diencephalon.(10)  
These regions are formed by nucleus ruber, which is responsible for the regulation 
and unconscious control of motor activity (this region is the most important area in 
patients with PD), and the SN, which is responsible for keeping muscle tone and 
coordination activities. Both belong to the dopaminergic system.(10) 
 Basal ganglia (Figure 2.1): Also known as the striate nucleus, this is the 
collection of GM in the cerebrum including the corpus striatum, amygdala and 
claustrum.(10) 
A large group of nuclei at the base of the cerebral cortex controls movement and 
coordination and affects involuntary movements.(10) It has meaningful connections 
with other regions of the brain, specifically the thalamus, subthalamic nuclei, red 
Brain Connectivity Analysis of Parkinson's Disease Patients. 
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nuclei and substantia nigra.(10) The basal ganglia include the caudate nucleus, 
putamen, globus pallidus, subthalamic nucleus, nucleus accumbens and substantia 
nigra.(10) 
In PD, there is a loss of dopaminergic innervation to the dorsal striatum and a 
cascade of consequences.(10) The putamen is responsible for regulating larger 
movements and exercises effects on various types of knowledge.(10) The caudate 
nucleus influences knowledge and memory, and is responsible for voluntary 
movements.(10) Lastly, the nucleus accumbens is related to mechanisms of 
pleasure and motivation.(10)  
Another important structure in the brain, specifically in patients with PD, is the 
thalamus.(10) Located between the cortex and the mesencephalon,(10) it is 
responsible for mood and movements associated with anger and fear. It is an 
important region of the central nervous system because nearly all brain nerves pass 
through (except the olfactory nerve).(10) 
At the subcortical level the hippocampus should be noted. This region belongs to the 
limbic system and has a role to play in the consolidation of information from short-
term and long-term memory, navigation, learning and emotion.(10) 
Lastly, the motor cortex is responsible for, and involved in, control, planning and 
execution mechanisms as well as voluntary movements.(10) It is located in the 
frontal lobe and includes three regions: the primary motor cortex (precentral gyrus), 
the premotor cortex (lying within the frontal lobe just anterior to the primary motor 
cortex – Brodmann area 6) and supplementary motor area (located in the midline 
surface of the hemisphere just in front of the primary motor cortex).(10) 
In addition, it is important to mention other regions of the cortex, such as the 
association cortex, responsible for ensuring that the movements are adaptive to the 
requirements of the organism and social context.(10) This region is compounded of 
the prefrontal and the parietal cortex.(10)  
Three routes of dissemination are identified: the nigrostriatal, mesolimbic and 
mesocortical pathways.(10) 
The first one starts in neurons of SNc and ends in the striatum.(10) It is associated 
with the transmission of information. Alterations in the dopaminergic system can 
result in information loss. This also occurs in the primary motor cortex.(10) 
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The mesolimbic pathway is also known as the “reward pathway” in the brain.(10) 
This pathway is also associated with the dopaminergic pathway.(10) It has 
projections to the nucleus accumbens, amygdala, olfactory nucleus, hippocampus 
and medial prefrontal cortex.(10) 
Lastly, the mesocortical pathway is a dopaminergic pathway that joins the ventral 
tegmentum to the cerebral cortex (in the frontal lobes).(10) 
 
 
Figure 2.1 – Illustration of basal ganglia and their components. The basal ganglia include 
the subthalamic nucleus and substantia nigra whose component structures are highly 
interconnected.(10) 
 
2.1.2 Scans Without Evidence of Dopaminergic Deficit Disease 
Scans Without Evidence of Dopaminergic Deficit (SWEDD) is the term created to 
refer to a group of patients that mystify this movement disorder through the absence 
of an imaging abnormality in those that have clinical, or are presumed to have, 
PD.(11) The acronym SWEDD does not offer any aetiological evidence; it has 
usually been used in the medical literature and clinical practice as a diagnostic 
label.(12,13) While many authors until now have said that this pathology is 
independent of PD, others have suggested that it can be a subtype of PD.(12,14) 
This kind of medical controversy has been studied to clarify what it represents.(12) 
Several studies involving patients with this term have been carried out and the 
results reflect that while most SWEDD cases are due to a clinical misdiagnosis of 
PD, there is a small quantity of patients with SWEDD that may have a subtype of 
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PD.(12–14) The continuing significance of this discussion has, as a consequence, 
led one of the largest observational organizations in patients with PD, the PPMI 
(http://www.ppmi-info.org/), to include patients with SWEDD.(12) 
With regard to the clinical follow-up of patients diagnosed with SWEDD, they are 
generally unresponsive to dopaminergic medication, adding to a non-existence of 
clinical progression, and preservation of olfactory function (usually compromised in 
PD).(11,14) Many studies discovered that dopamine deficiency did not develop 
constantly, nor did subjects improve their hypermetabolism in the basal ganglia, with 
hypometabolism in the parietal cortex (particularly the premotor and posterior 
regions) being typical of PD.(11,14) Since 2013, several studies have described that 
SWEDD patients might have dystonic tremor.(11) However, clinical findings were 
related to three groups. Specifically, true fatigability and decrement, re-emergent 
tremor on variation in posture and the presence of non-motor irregularities facilitated 
a diagnosis of PD.(11,14) It is also important to mention that a lack of true 
bradykinesia, head tremor and dystonia was more indicative of SWEDD.(13) 
Additionally, another study demonstrated enhanced facilitation and loss of spatial 
specificity typical of dystonia in a subsection of SWEDD patients.(13,14) 
Repeated clinical studies revealed that SWEDD patients may have a better 
prognosis than PD and this may be advantageous for the quality of life of the 
patients.(11,14) 
Clinical evaluation with constant examinations every several months can help to 
clarify the difference between PD and SWEDD and there should be no need to start 
symptomatic therapy.(14) However, to achieve early diagnosis and differentiation 
between the two diseases, a neuroprotective therapy should be available.(14) When 
the clinical examinations are still unclear, neuroimaging (functional imaging) could be 
a second criterion.(13,14)  
Lastly, many studies revealed that one-half of the SWEDD patients had a positive 
familial history compared to only 1/6 of the PD patients.(13,14) Once again, 
neuroimaging could be useful and advantageous in differentiating between 
pathologies.(13)  
It is important to mention also that the UPDRS is used to follow the longitudinal 
course of Parkinson’s and SWEDD diseases. The UPDRS is a scale that was 
developed in an effort to provide a comprehensive, efficient and flexible means to 
monitor PD-related incapacity and impairment. Normally, the scale has four 
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components, largely derived from previous scales that were modified by a group of 
specialists in PD (Part I, Mentation, Behaviour and Mood; Part II, Activities of Daily 
Living; Part III, Motor; Part IV, Complications). 
 Table 2.1 summarizes the differences between PD and SWEDD. 
  
Table 2.1 – Clinical differences between PD and SWEDD 
 
Features 
 
PD 
Responsive to dopaminergic 
medication, clinical progression 
and affection of olfactory function. 
 
 
SWEDD 
Unresponsive to dopaminergic 
medication, non-existence of 
clinical progression, preservation 
of olfactory function, lack of true 
bradykinesia, head tremor and 
dystonia. 
 
2.2 Diffusion Weight Imaging and its principles 
Brownian motion is characterized by the consequence of a random microscopic 
motion of diffusion molecules, also called “diffusion phenomena”.(15,16) This effect 
reflects the movement or stagnation of every molecule or particle in a fluid, which is 
also thermal molecular energy.(15) 
Particles in a free medium have a random direction and change all the time (random 
walk).(15,16) When the concentration has a stable situation, diffusion can be defined 
mathematically, or otherwise statistically, when the situation is unstable and the 
diffusion can be observed and measured (resulting in macroscopic flux of the 
fluid).(16) 
The diffusion phenomena respect a Gaussian distribution (with a zero mean) and the 
variance is proportional to time: 
 
< 𝑟2 > = 2 𝑁𝐷𝑡                                                                   (1) 
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where < 𝑟2 > is the mean square displacement and N (for MRI measurement 
purposes, this value is one) is the “dimensionality” of the space in which diffusions 
are measured.(15,16) D is the diffusion coefficient and defines the movement of 
particles in a fluid at a certain temperature (D has molecular size and temperature 
dependency, and the environment that it is inserted in is also an important 
factor).(15,16) The methods executed in diffusion-weighted imaging (DWI) measure 
(indirectly) the shifts of the molecules in one dimension.(15,17) 
By exploring the natural sensitivity of MRI to motion, it is possible to measure 
diffusion in vivo. In MRI, we see different phase shifts in accumulative spins (this 
accumulation occurs due to natural Brownian motion), resulting in a lower MR signal 
intensity.(17) 
In a clinical situation, these properties are small, and extremely difficult to measure 
and study, but we can increase sensitivity to motion using higher field gradient 
pulses in a pulse sequence.(16) The simplest pulse sequence in MRI consists of a 
spin–echo sequence with two extra gradient pulses placed around the refocusing 
pulse (Figure 2.1).(16) During the first gradient pulse, spins sitting at one specific 
Larmor frequency in different positions on the magnet bore are shown as different 
magnetic fields.(17) However, they accumulate different phase alterations.(15,17) It 
is also important to point out that when the spins stay immobile, the phase 
accumulated during the second gradient pulse is identical to the phase accumulated 
during the first gradient pulse since the first phase shift is reversed by the 180º pulse, 
and the net phase shift is zero.(15) What happens to a group of diffusing spins 
moving arbitrarily? The result consists in spins not having the same gradient field 
during the two pulses.(16,17) When needed to acquire the echo time (TE), the phase 
shifts will be arbitrarily dispersed, resulting in an imperfect refocusing of the 
sequence and signal attenuation.(16) This attenuation will have a positive correlation 
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with D.(16) 
 
Figure 2.2 – Illustration of application of two diffusion gradients.(17) 
What do isotropy and anisotropy state mean? The first definition is when the human 
body does not have any barrier to the motion of spins;(16,18) however, the second 
has a different behaviour. In other words, it is once we have alteration in Brownian 
motion (for example, the axonal fibres provoke a low mean diffusivity), changing the 
molecular direction in a certain path (normally, the molecules have a perpendicular 
direction when they do not have any obstacle, however with barriers to motion the 
molecules will have a parallel path).(17,18) 
Due to the influence of the motion of spins, a gradient with a certain intensity (𝐺) and 
length (𝐿) is applied, which will provoke a spin phase shift in each voxel.(16,18) After 
a TE/2 time, a 180º RF pulse is applied, which is responsible for the inversion of the 
phase of the spins. After a timed interval, following the start of the first gradient, a 
second gradient is applied that causes refocusing of spins.(16,17) However, the 
spins will retain a residual gap allowing the quantification of the diffusion that 
occurs.(15,17)  
When the diffusion gradients and their sensitization effect on molecules are 
mentioned, it is important to take into account the arrangement of the sequence. 
Thus, the signal to obtain, for a voxel of tissue in which molecular diffusion occurs, is 
equal to the intensity of a T2-weighted image, i.e. equal to that which would be 
obtained if the diffusion gradients were not applied with a decrease due to the 
reduction of signal resulting from the loss of coherence associated with the 
displacement suffered by molecules.(15,17) 
The expression giving the measured signal intensity is: 
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𝑆 =  𝑆0𝑒
−𝑏𝐷                                                                      (2) 
 
where S0 is the signal intensity without DWI and b is a factor that reflects the strength 
and timing of the gradients used to generate DWI images.(17) 
When a longer time is considered there will be a higher molecular shift, which 
causes greater attenuation in the weighted signal diffusion.(16,17) Gradients with 
larger amplitude and duration are in turn responsible for contrast enhancement in the 
signal, by inducing a higher shift phase in molecules that are subject to the diffusion 
process.(15,17) However, if ADC maps are considered, areas of higher intensity 
correspond to regions of higher diffusivity, because this method is sensitive to the 
diffusion length.(17) To estimate the ADC, we need to obtain at least two images, 
corresponding to different b values.(17,18) 
In 1985, clinicians applied the use of one new sequence, echo-planar imaging 
(EPI).(15,16) The main aim of this sequence was to reduce the acquisition 
time.(17,18) The basic principles of this sequence are nearly identical to those of the 
spin echo, however the newest sequence needs just one excitation pulse, which is 
why the sequence is also called “diffusion-weighted single-shot echo-planar imaging” 
(DW-SS-EPI) (Figure 2.3).(16) As previously mentioned, the greatest improvement 
was the reduced acquisition time due to the capacity of the system to acquire in 
“just” one time repetition (TR). However, as a consequence, this sequence has a low 
signal-to-noise ratio (SNR) and is prone to high artefacts.(16) These artefacts are 
duo to spatial fluctuations in magnetic susceptibility.(17,19) 
Other sequences have been developed, such as EPI-Multi-Shot (Figure 2.4), where 
the k-space is obtained with several TRs,(17) resulting in the reduction of the 
effective time between the echoes.(17) As a consequence, this sequence increases 
the acquisition time, but on the other hand, we have better SNR and resolution and 
fewer artefacts.(16,17) 
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Figure 2.3 – Illustration of EPI single-shot 
sequence.(16) ETL= echo train length. 
 
Figure 2.4 – Illustration of EPI multi-shot sequence.(16)  
 
2.2.1 Diffusion Tensor Imaging 
DWI is an MRI technique that is defined by the application of magnetic ﬁeld gradient 
pulses to study water diffusion.(17,18) Water diffusion is the main basis of DWI and 
refers to the arbitrary translational motion of molecules.(15) Normally, diffusion 
gradients are applied along the three axes (x,y,z) of the scanner.(16,17) DWI 
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enables the acquisition of the trace and mean diffusivity (MD). The mathematical 
formula(18) for calculating the trace is: 
 
𝑇𝑟(𝐷) =  𝐷𝑥𝑥 + 𝐷𝑦𝑦 + 𝐷𝑧𝑧                                                      (3) 
 
where Dxx, Dyy and Dyy are coefficients along the x, y and z axes. 
 
The MD is defined as:  
 
𝑀𝐷 =  
𝐷𝑥𝑥 + 𝐷𝑦𝑦 + 𝐷𝑧𝑧
3
 =  
𝑇𝑟(𝐷)
3
                                              (4) 
 
Diffusion tensor imaging (DTI) involves the application of diffusion gradients in at 
least six directions.(17,18) This technique offers other indices with the orientation of 
diffusion and the central path of diffusivities. However, to improve this technique, the 
acquisition of more than six directions is recommended.(18) Anisotropy is the 
directional dependence of diffusion, which defines the spatial variations of water 
molecular shifts (Figure 9).(18,19) Anisotropy is defined by the fractional anisotropy 
(FA) parameter and demonstrates the presence of oriented structures such as axons 
in ﬁbre bundles. FA is characterized by: 
 
𝐹𝐴 =  √
1
2
. √
(𝜆1− < 𝜆 >)2  + (𝜆2− < 𝜆 >)2  +  (𝜆3− < 𝜆 >)2 
(𝜆1)  +  (𝜆2)  +  (𝜆3)
                      (5) 
 
where 𝜆1, 𝜆2 and 𝜆3 are the eigenvalues of each diffusion direction. The central path 
of diffusion and the direction perpendicular to it are calculated by the spatial 
alignment of these components.(19,20)  
Another important scalar function or invariant that can be identified from the diffusion 
eigenvalues is relative anisotropy (RA).(17) This function is given by: 
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𝑅𝐴 =  √
3
2
. √
(𝜆1− < 𝜆 >)2  +  (𝜆2− < 𝜆 >)2  + (𝜆3− < 𝜆 >)2 
(𝜆1)2  +  (𝜆2)2  +  (𝜆3)2
                      (6) 
 
DTI was developed to measure the diffusion tensor in each voxel, enabling the 
estimation of MD values or degrees of anisotropy in each voxel (Figure 2.5). An 
anisotropic statement is when the value is 1, however when the value is 0 it is 
isotropic.(17,18) The signal can be obtained by:  
 
𝑙𝑛
𝑠
𝑠0
 =  ∑ ∑ 𝑏𝑖𝑗𝐷𝑖𝑗
3
𝑗
3
𝑖
                                                             (7) 
 
bij represents one matrix
 (17,18) with values b and Dij is the tensor diffusion defined 
as: 
 
𝐷 =  [
𝐷𝑥𝑥 𝐷𝑥𝑦 𝐷𝑥𝑧
𝐷𝑦𝑥 𝐷𝑦𝑦 𝐷𝑦𝑧
𝐷𝑧𝑥 𝐷𝑧𝑦 𝐷𝑧𝑧
]                                                    (8) 
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Figure 2.5 – Illustration of anisotropic (up) and isotropic (down) direction with the ellipsoid 
demonstration of the single tensor model.(17) 
 
Diffusion directions (Figure 2.4) are represented by eigenvectors oriented along the 
main direction of diffusion (e1, axial or even parallel) and perpendicular to it (e2 and 
e3, radial or perpendicular) and by their respective diffusivities, or 
eigenvalues.(17,21) Anisotropy is still a process that is not completely defined and 
understood.(17,21) It reﬂects the organization in bundles of ﬁbres running in 
parallel.(17,18) It is usually recognized that variations in transverse diffusivity mostly 
reﬂect transversal loss,(21) but alterations in radial diffusivity (RD) can express 
myelin damage.(17,22)  
FA and RA both have a numerator variance associated with three eigenvalues. 
These two scalar functions allow the mean ADC (apparent diffusion coefficient) 
along the three orthogonal axes to be calculated. It is also normal to generate a 
colour map (RGB system – red, green and blue) where the intensity is given by the 
value of FA (Figure 2.6).(18) This system allows a more direct view of “neural” 
directions (blue corresponds to superior-inferior, red diffusion in the lateral-medial 
axis, and the green component diffusion according to the anterior-posterior 
axis).(17,21) 
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Figure 2.6 – Quantitative maps of DTI measurements. Left to right: T2-weighted reference image (i.e. 
b=0 s/mm2), the mean diffusivity (MD), fractional anisotropy (FA; hyperintense in white matter), the 
major eigenvector direction indicated by RGB colour map (red: right-left; green: anterior-posterior; 
blue: superior inferior).(22) 
 
2.2.2 Tractography and its algorithms 
Tractography is the only currently existing tool capable of identifying and measuring 
existing anatomical connections in the human brain in vivo, in a non-invasive 
way.(21,22) This technique enables identification and characterization of the nervous 
system that would otherwise only be possible using more conventional and invasive 
methods, such as axonal tracing using injected radioisotopes.(20,22) 
Instead of using the RGB system to visualize the orientation of major eigenvectors, 
tractography enables the 3D visualization of white matter connections (anatomy and 
connectivity between numerous regions).(18,20) 
In tractography three vital fibres exist and they are nominated throughout their 
location and according to their connections (Figure 2.7). They are: 
 Association Fibres – These fibres connect regions inside the same 
hemisphere, with anterior-posterior direction.(21) 
 Projection Fibres – They are responsible for the signal transmission between 
the cortical and subcortical regions in a superior-inferior direction.(21) 
 Commissural Fibres – Establish the edge between both hemispheres.(21) 
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 Figure 2.7 – White matter fibre tracts seen with DTI 
Tractography (256 diffusion directions).(18) 
 
The principal aim of this method is to reconstruct the direction of neuron bundles in 
the brain of patients undergoing MR-DTI.(17,21) This tool can detect the main 
direction of water movement in the brain thought to coincide with the behaviour of 
neuronal WM as a result of its deterministic tractography technique and its value as 
a surgical planning tool.(17,22) 
Tractography can normally be generated with two main algorithms: deterministic or 
probabilistic.(20) 
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In this work, only the deterministic algorithm is considered. Although the number of 
voxel connections in the deterministic algorithm is more limited, the reconstructed 
connections provide higher connectivity values than some of the trajectories 
reconstructed by probabilistic tractographies.(17,20) This is because the latter 
method produces a great diversity of paths for the fibres,(17,20) whereas in the 
former, the fibres tend to follow the same trajectory in most cases, demonstrating the 
consistency of this algorithm and resulting in higher connectivity values.(17)  
It is paramount to mention that all algorithms share the same heuristic rules on the 
termination of reconstruction.(17,19) Thus, the reconstruction ends for one of two 
reasons: the front streamline reaches a region where the value of FA is less than a 
predetermined value (threshold), or if the angle between voxels exceeds a 
predefined threshold.(20) 
If the reader wants more detailed information about reconstruction and propagation 
algorithms, the reading of Diffusion MRI: From Quantitative Measurements to In Vivo 
Neuroanatomy is recommended.(17) 
Deterministic algorithms were the first to be invented and they are the most 
commonly used in clinical applications.(17) Deterministic algorithms try to discover 
the path from an original voxel based on the main direction of diffusion in each voxel 
path, not taking into account the uncertainty related to this approximation.(21,23) 
The deterministic approach is only able to rebuild a streamline by voxel (a streamline 
is a curve tangent to the vector field). However, this approach has some limitations, 
such as the inability to identify fibres branching or take into account the uncertainty in 
the estimated parameters.(22,23) 
The most common examples of deterministic algorithms (Figure 2.8) are Fibre 
Assignment by Continuous Tracking (FACT) and Fibre Assignment by Continuous 
Tracking Including Diagonals (FACTID).(22,23) 
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Figure 2.8 – Deterministic algorithms: FACT (top row) permits the propagation streamlines and 
FACTID (bottom row) enables the propagation diagonally.(23) 
 
The top row of Figure 2.8 and Figure 2.9 demonstrates the explanation of streamline 
reconstruction with the FACT algorithm using four test tracts (dotted lines, direction 
of propagation given by small arrowheads) incoming and crossing the bottom-left 
voxel in the direction of highest diffusion or the upper-right voxel (dual-direction 
arrow).(21,23) However, the FACT approach does not allow the diagonal path.(23) In 
other words, the orientation of the axes powerfully disturbs the estimated tracts, 
producing numerous artefacts (present in the calculations, due to signal noise and to 
grid dependence).(23) In fact, if the reference was rotated 45º, this propagation could 
occur.(21,23) Nonetheless, the diagonal orientation of the axes can actually occur 
and be detected with the FACTID reconstruction algorithm,(23) allowing the 
possibility of spreading each WM tract for eight voxels of their neighbourhood (2D) or 
26 in the case of 3D instead.(21,23) The FACTID shows more tolerance relatively to 
the orientations of the axes and therefore this approach is also characterized by 
better SNR than the FACT.(22,23) 
DTI has other limitations, such as SNR and low resolution, as well.(21,23) To 
overcome these limitations and to correct the fibres’ orientation heterogeneity in 
each voxel, other methods and techniques have been developed.(21,22) Examples 
of these are Q-ball, spherical deconvolution (SD), diﬀ usion spectrum imaging (DSI), 
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diﬀ usion kurtosis imaging (DKI) and high-angular resolution diffusion 
imaging (HARDI).(21,22) 
The DTI and tractography are a very useful technology that are used to study several 
questions which the brain connectivity. 
 
Figure 2.9 – In the deterministic method the principal direction of diffusion is characterized by the axis 
of diffusion of ellipsoids. The white line represents the streamline obtained after the various regions 
according to the preferred diffusion direction estimated at each voxel being connected.(23) 
 
2.3 Brain Connectivity 
The brain is never idle. Even when resting, a large number of neuronal activities are 
happening in many areas of our brain. 
Brain connectivity has revealed the multifaceted brain organization through 
innumerable networks (21,24) allowing the segregation and integration of information 
during high cognitive processes, but also the definition of clinical consequences of 
alterations encountered in the development of neurological diseases.(21,24) 
These complex interactions can be studied by applying imaging methods, which, 
through anatomical and functional properties of the brain structures, can be 
measured simultaneously.(21,24) However, most brain imaging studies employ a 
multivariate functional analysis, where each brain region is studied together with 
reference to others.(24,25)  
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The structural or anatomical connectivity defines the white matter networks between 
brain regions.(21,22) Brain connectivity is usually represented by a binary or 
weighted network whose topology can be studied using the graph theory.(24,25) 
Functional connectivity is defined as statistical dependencies among remote 
neurophysiological events, which can analyse statistically many regions combining 
the regions of interest and based on anatomical or structural information that is 
quantified with measures of statistical dependencies, such as correlations, 
coherence or transfer entropy.(21,24) However, the associations can arise in a 
variety of ways.(24,26)  
The main problem with functional connectivity analysis is the complexity due to the 
quantity of links that could be analysed.(27) In other words, the number of 
combinations always depends on the areas/regions that are involved, making it 
practically impossible to obtain reliable solutions.(25,27) On the other hand, if 
analyses of structural connections are performed, then the number of functional 
networks to be studied can be limited.(25,27) 
Finally, the last connectivity method is called the “effective connectivity network”,(25) 
which measures the influence that one neural system applies over another.(25,27) 
To underline the mechanism of anatomical (structural), functional and effective 
connectivity in the whole brain, the graph theory has demonstrated an important role 
in this area of study.(27) Below, the fundaments of this mathematical model are 
explained. 
 
2.4 Graph theory – The Fundaments 
Over the past 20 years neuroscience has become one of the most important areas of 
study and scientific research, especially neuroimaging. In recent years,(25,28) an 
exponential increase of research in human neural networks – connectivity brain 
systems – has been seen.(25,28) 
A network (or a graph) is a mathematical model that involves a group of nodes (or 
vertices) and connections (or edges) between pairs of nodes.(28) This group of 
nodes and connections is an abstract model that can be used to characterize the 
different levels of the brain systems.(28) An edge can represent functional or 
structural connections between the cortical and subcortical nodes, if based on data 
analysis of human neuroimaging.(2,28) Once the brain connectivity matrix is 
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constructed, its properties and topologies can be quantified by a variety of measures 
that have been recently developed in the field of statistical physics of complex 
networks and graph theory.(2,25) 
All connections explain the network properties of each graph. Figure 2.10 represents 
two types of network model, where the simplest case (unweighted undirected 
networks) assumes that each connection has the same strength or length and the 
edges are bidirectional (meaning that the information can travel between the edge 
from A to B node and/or vice versa).(28) It is also important to point out that in 
unweighted networks, edges are absent (0) or present (1).(25,28) The second 
network case is weighted, which means that the edges may differ from each other 
with different strengths,(28) or some physical distance between the connected 
vertices.(2) Each connection with a different strength or length represents one 
precise weight.(25,28) Lastly, a network could be directed if its links are 
unidirectional (the information travels just in one way or direction).(24,28) Normally 
graphs can be graphically described by plotting the nodes and edges(24,28) 
according to their estimated measures(24,28) but the most valuable format for 
representing networks is their matrix form.(25,28) 
 
Figure 2.10 – Unweighted graph (left) and Weighted graph (right). In the Unweighted graph each 
connection has the same strength or length and the edges are bidirectional. In the Weighted graph the 
edges may differ from each other with different strengths, or some physical distance between the 
connected vertices.(28) 
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2.4.1 Network measures and types 
The precise quantification of network metrics is the most significant advantage of 
theoretical network analysis, because it enables the diagnostics of network topology 
and efficiency.(22,24)  
There is a quantity of measures that can describe quantitatively a network. In this 
section, the most significant measures and types of networks are described. 
Node (or vertex): This is the basic element in the graph theory (28) where node 𝑣 
represents an intersection point of a graph.(24,28)  
Edge (connections or links): This is the link between two nodes or vertices (Figure 
2.10)(24) where the edge 𝑒𝑖,𝑗 represents the initial extremity, for example 𝑖, and the 
terminal point, 𝑗.(24) 
Degree: This is one of the most basic and important measures and is often 
represented by k.(21,28) The degree is the number of edges within a specific 
node.(24,28) The degree of distribution gives the probability that a randomly chosen 
node will have degree k.(28) The shape of the degree distribution provides 
information about the structure of the graph.(22,28) As described above, different 
types of graphs have their individual typical degree distribution (Figure 2.11). 
Clustering coefficient (ClusC): Clustering is an important property in social networks. 
It is defined as the probability of the degree to which two random node neighbours 
are connected to each other.(21,28) The ClusC of a vertex can have values of 
between 0 and 1.(24) The ClusC 𝑐𝑖 of node 𝑖 with degree 𝑘𝑖 can be defined as the 
ratio of the actual number of links between neighbours of 𝑖, i.e. 𝑚 and 𝑖 (𝑒𝑖), to the 
maximum possible number of links between those neighbours (neighbours of 𝑖 are 
nodes directly connected to node 𝑖).(24) When good interconnection exists between 
the neighbours we have high clustering coefficients.(24) This suggests a better 
protection against the loss of an individual node (little impact on the structure of the 
network).(24,28) 
𝑐𝑖 =  
2𝑒𝑖
𝑘𝑖 (𝑘𝑖 − 1)
 =  
∑ 𝑎
𝑖,𝑗
𝑎
𝑗,𝑚
𝑎𝑚,𝑖𝑗,𝑚
𝑘𝑖 (𝑘𝑖 − 1)
                                              (9) 
 
where 𝑎 is the edges between nodes. 
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Characteristic path length or lambda (L): The characteristic path length 𝐿 of a 
network is the average distance between all pairs of nodes.(22,28) The path length 
or distance 𝑑𝑖,𝑗 between two nodes 𝑖 and 𝑗 is the smallest number of links that can 
connect 𝑖 to 𝑗.(28) For an undirected graph of 𝑁 nodes, the mean path length is: 
(24,28)  
𝐿 =  
1
𝑁(𝑁 − 1)
 ∑ 𝑑𝑖,𝑗
𝑖,𝑗∈𝑁,𝑖≠𝑗
                                                       (10) 
Distance matrix (Dist): This is a two-dimensional matrix that covers the distances, 
taken pairwise, between nodes.(4,28) In a weighted graph, the distance between two 
vertices can be defined as the minimum of the sums of the weights on the shortest 
paths joining the two vertices.(4) 
Assortativity: This is the correlation between the properties of the nodes linked 
directly by a path. Theoretically, the graph is assortative if vertices with a high 
degree tend to be linked to other vertices with a high degree, and vertices with a low 
degree are linked to other lowdegree vertices (positive degree correlation).(4,28) On 
the other hand, a disassortative graph is represented by a negative degree 
correlation.(4,28) The average degree 𝑘𝑛𝑛 of the neighbours of a node with degree 𝑘 
is given by:  
𝑘𝑛𝑛(𝑘) =  ∑ 𝑘´𝑃 (𝑘´|𝑘)
𝑘´
                                                      (11) 
where 𝑃 (𝑘´|𝑘) is the conditional probability that a path of node degree k´ points to a 
node with degree k. Most of the technological and biological networks tend to be 
disassortative, whereas the social networks tend to be assortative.(24,28) 
Betweenness centrality (betw): This is the index of the relative relevance of a node 
or edge.(22,24) In other words, this is the number of shortest paths that a node or 
edge participate in.(24,28) It is expressed by the equation: 
𝑏𝑖 =  ∑
𝑛𝑗,𝑘(𝑖)
𝑛𝑗,𝑘
𝑗,𝑘∈𝑁,𝑗≠𝑘
                                                          (12) 
 
This is the ratio of all the shortest paths between node 𝑗 and 𝑘 that are passed 
through by a path’ 𝑖 (𝑛𝑗,𝑘(𝑖)).(22,28) Later it is necessary to be divided by all the 
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shortest paths between nodes 𝑗 and 𝑘 (𝑛𝑗,𝑘).(22) This mathematical model explains 
the consequences of the loss of a particular edge or vertex.(28) 
Edge Betweenness (Edge Betw): The characterize the fraction of all the shortest 
paths covering a specific edge,(22,28) meaning that edges with high values of 
betweenness centrality contribute to a large number of short paths.(22,24) 
Local Efficiency: Represents the mean of the efficiencies of all subgraphs of 
neighbours of each vertex of the graph.(28) 
Global Efficiency: This is the inverse of the shortest distance in the network (between 
vertices).(21,28) 
Graph Eccentricity: Represents the maximum length of the shortest path between 
any nodes.(21,24) The radius of G is the value of the smallest eccentricity.(22,28) 
The diameter of G is the value of the highest eccentricity.(28) 
Hub: This is a nuclear portion in the architecture of the network.(28) It receives all 
neural synapses and transmits to the others (Figure 2.11).(24,28) Hubs can be 
distinguished by using many different graph measures;(28) most of them reflect 
aspects of node centrality.(22,28) The simplest network measure used for classifying 
hubs is the node degree, also called “degree centrality”, which is equivalent to the 
number of edges that are preserved by each node.(28) 
 
Figure 2.11 – The network’s architecture. (A) Nodes or vertices (describing neurons/brain regions) and 
edges (represent functional or structural connections between the cortical and subcortical nodes). (B) A 
path length resembles a sequence of edges that are traversed when travelling between two nodes. 
Low-degree nodes are nodes that have a low number of edges and high-degree nodes (often referred 
to as “hubs”) are nodes that have a high number of edges. (C) Numerous Hubs. Connector hubs can 
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establish connections between modules (high degree). Provincial hubs are high-degree nodes that 
connect to nodes in the same module.(28) 
 
Vulnerability and dynamic importance: Tries to assess the impact of node (or edge) 
removal with respect to the global network synchronization or communication by 
associating graph metrics before and after node (or edge) deletion.(24) 
Deg, ClusC and L are core measures of the graph theory network (24,28) and with 
them, four different types of graph can be extracted. They are described as follows 
(Figure 2.12).(24,28) 
Ordered or lattice-like network: Each node is linked to its 𝑘 adjacent 
neighbours.(2,28) The meaning of “adjacent” depends on the dimension considered 
in which the network is demonstrated.(2,28) If the network is considered with one 
dimension the theoretical values of ClusC and L are high and large, respectively.(24) 
Small-world network (small-worldness): This network refers to the collective of 
networks in which the mean geodesic or shortest path distance between nodes 
increases satisfactorily slowly as a function of the number of nodes in the 
network.(24,28) Can be thought of as a lattice-like network where a small fraction of 
the edges has been arbitrarily rewired.(24,28) This network has a C close to that of 
an ordered network, however it has a very small L close to that of a random 
network.(21,28) 
Random network: All links are arbitrarily rewired to pairs of nodes and possess short 
L and small ClusC values.(21,24) 
Scale-free network: A scale-free network is a connected graph with a property of 
some of the edges originating from a given node exhibiting a power law 
distribution.(21,28) When nodes are detached from a random network, the 
connectivity of the random network decays slowly with time until the network reaches 
a point where it breaks into smaller distinct domains that are unable to connect.(28) 
On the other hand, scale-free networks resist random failures, because it is 
statistically unlikely that the strongest connected nodes would fail under random 
conditions.(25,28) 
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Figure 2.12 – Examples of network architectures. The left graph is a network with 16 vertices where 
each one binds to four neighbours. This is a regular/ordered graph that has a high ClusC and a long 
path length. In the case of p = 1 the graph becomes entirely random and has low ClusC and a short 
path length. Lower p values arise as attributes called “small world”, which combine high ClusC values 
with short path length.(24) 
 
2.5 State of the art of brain connectivity in Parkinson’s Disease 
The DTI technique has become one of the most important tools used for the study of 
white matter structure in the normal brain,(26,29) while fMRI has become a 
technology reference for validating the results provided by the DTI method.(5,29,30) 
One of the ways to measure water motion is through anisotropy (FA). Lower FA 
values mean a decrease in fibre coherence of connecting tracts and higher MD 
values translate to an increase of diffusivity of water molecules in intra- or 
extracellular spaces.(26,29)  
Many studies mention that FA is extremely sensitive, but that it is not a very specific 
biomarker of neuropathology.(44,45) 
However, several investigations have demonstrated that a DTI is certainly a sensitive 
marker of neuropathology. In this study, MD, FA and connectivity metrics were used 
as sensitive markers of neuropathology.(44,45)  
Numerous studies (structural, functional and effective brain connectivity studies) and 
clinical applications using DTI have been performed in PD patients.(30–32) Theories 
have been suggested about the brain structures affected. Normally, the studies are 
based on the analysis of ROIs, and use voxel-based analysis (VBA) to study the 
structural changes in PD.(31–34)  
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Preliminary work has shown that DTI may have an important role in the diagnosis of 
PD.(21) In fact, in most studies, the FA value in SN on DTI was lower among PD 
subjects when compared to healthy controls and correlated inversely with the clinical 
severity of PD.(29) According to Claire J. Cochrane and Klaus P. Ebmeier (29), DTI 
may be a favourable biomarker in Parkinsonian syndromes. However, they suggest 
combining the DTI biomarker with another biomarker due to the complexity of these 
syndromes.(29) 
Normally PD is manifested by motor symptoms asymmetrically. Prakash et al.(35) 
investigated 11 patients with PD and 12 healthy patients, and they observed that MD 
and FA values are significantly different between the two hemispheres in the rostral 
SN of patients with PD (p<0.005 and p<0.00005, respectively).(35) These patients 
presented with significantly higher MD values in the left rostral SN than healthy 
patients.(35) 
Other studies using DTI have shown the importance of this technique. Anna Hotter 
demonstrated abnormal results in patients with PD on DWI that have rarely been 
reported.(35) The same author detected a reduction in FA in the SN and 11 ROIs 
along a line between the SN and striatum segmented on axial slices of seven 
patients with early PD.(35) She interpreted this result as a sign of the well-known 
damage of nigrostriatal projection in early PD.(35) Other authors found reduced FA 
values in the white matter of the premotor area in advanced PD cases. Scherfler et 
al.(36) found MR structural modifications of the olfactory region in patients with PD 
(they applied voxel-wise analysis on trace maps).(36) These results confirmed 
clinical ﬁndings, in other studies, of hyposmia in PD.(36) However, Yoshikawa K et 
al.(37) investigated possible changes in FA in the nigrostriatal pathway in PD 
patients. They studied 12 patients with PD and eight Controls using DTI 
technique.(37) The FA values (ROI defined by the line between the SN and the lower 
limit of the putamen) were compared with equivalent measurements in Control 
subjects.(37) They found that there was a significant decrease of these values in 
patients, even at an early stage of the disease.(37) These results again reinforced 
the theory that the decline in FA is closely connected with the loss of dopaminergic 
neurons in subjects with this disease. 
In 2013, Baradaran N et al.(30) submitted ten patients with PD and ten Controls to 
functional MRI tests (fMRI) to determine the pattern of connectivity associated with 
clinical stiffness found in patients with PD.(30) They also examined the connection 
between this clinically proven stiffness and motor performance metrics.(30) They 
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found that cortical and extensive subcortical networks are associated with this rigidity 
observed in patients with PD, which supports and reinforces the importance of the 
change in functional connectivity in subjects with PD.(30) 
Massimo F et al.(31) analysed the functional connectivity in patients at an early 
stage of PD, using 69 patients including 44 on medication to affect dopaminergic 
Control (tPD), and 25 without relevant medication (nPD) and 27 Controls. tPD 
showed reduced functional connectivity in the striatum and thalamus and augmented 
functional connectivity in the temporal and occipital regions compared to Controls 
and nPD.(31) They also found that both tPD and NPD subjects with major motor 
weakness showed a higher increment in effective connectivity in the thalamus and 
striatum region.(31) 
In addition, graph theoretical analysis has been used in several studies to show 
brain-behaviour covariance patterns, nodal strength, latent variable values, caudate 
dopamine transporter (DaT) uptake modularity of the intellectual circuitry and 
caudate DaT binding in patients with PD.(32) One of the main aims of these studies 
was to explore the resting state fMRI correlation to cognitive impairment in patients 
with PD, and to measure the impact of dopamine deﬁciency on brain 
systems.(5,8,32) In one of these studies, thirty PD patients with resting state fMRI 
were included from the PPMI database.(32) The authors also examined 18 patients 
from this sample with 123I-FP-CIT SPECT. They found that PD-related executive 
impairment was related to altered stability between cortical and subcortical 
processing at rest, when the influence of the dorsal cortex became abnormally 
suppressed, and subcortical processing was disinhibited.(32)  
Despite the value of these studies, a multimodal approach and graph theoretical 
analysis have not yet been applied together for illuminating the brain mechanisms of 
PD.(32) 
The DTI methodology based on graph theory was also used in some studies with PD 
patients to define and describe the specific connections between different areas in 
the brain, specifically in different regions of GM, and to estimate also the 
relationships between them, using a combination of the anatomical connectivity 
measures obtained and correlations with neurocognitive and motor evaluations.(38) 
This methodology enables the underlying neural mechanism in the early stages of 
PD to be described.(38) Batista K et al.(38) used graph theory methodology with DTI 
to quantify the anatomical connectivity between GM zones through three measures: 
anatomical connectivity strength (ACS), anatomical connectivity probability (ACP) 
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and anatomical connectivity density (ACD).(38) They revealed that cognitive and 
motor deterioration in the early stage of PD is connected with microstructural WM 
damage extended to the frontal, parietal and temporal regions.(38) They suggested 
that DTI combined with neurocognitive tests would be a valuable biomarker for 
identifying cognitive impairment in PD.(38) 
Sousa et al.(21) found changes in structural connectivity measures in PD patients. In 
particular, a decrease in node degree and an increase of MD in the Globus Pallidus, 
and a decrease of FA in the nucleus accumbens were observed.(21) They also 
found an increase of brain connectivity in the parahippocampal gyrus (anterior 
region).(21) Between brain hemispheres, they found changes in the hippocampal, 
postcentral, precentral, planum temporale and temporal superior (posterior region) 
gyrus.(21) 
Ticló et al.(22) also studied, using a similar methodology, two groups of PD subjects 
in different disease stages (de novo PD and PD 2 to 5 years) and compared them to 
a Control group over one year.(22) The authors found that FA was consistently 
augmented in the frontal cortex, suggesting a compensation for the reduction of FA 
in other areas classically affected by PD.(22) They also detected a decrease in the 
number of connections of the neural network in PD 2 to 5 years, 1 year after the first 
acquisition.(22) Finally, a reduction of transitivity, number of edges and network 
density in PD 2 to 5 years was also observed in comparison to the Control 
group.(22) Consequently, connectivity analysis may be useful in earlier PD diagnosis 
biomarker investigation, and for this reason, new studies are suggested with a larger 
number of patients.(22) 
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3. Materials and Methods 
In this section, the PPMI database will be described, followed by a description of the 
subject groups and the MRI protocols that were used. At the end of this section, the 
method of processing and analysis of data implemented by the MIBCA toolbox, as 
well as the statistical methods used with SPSS, will be explained. 
 
3.1 Parkinson’s Progression Markers Initiative database 
The PPMI database (https://ida.loni.usc.edu/) was the source of the data used in this 
thesis.  
Our population consisted of 1071 adults, aged 38 to 82 years old, and included 
patients with normal cognitive state, SWEDD and PD. 
The following factors were taken into consideration when selecting the sample: at the 
time of the examinations, some subjects were taking dopaminergic medication and 
their T1-w and DTI exams were performed after 12 months of diagnosis. The first 
group represented the healthy group, the second represented the patients with 
SWEDD and the last group represented subjects diagnosed with PD. The 
characterization of those groups (number of patients, gender, age, UPDRS) is shown 
in Table 3.1.  
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Table 3.1 – Characterization of Subject Groups – Demographics, Years of Education and UPDRS 
 
Control SWEDD PD 
N 30 29 29 
Gender 9F/21M 13F/17M 11F/19M 
Age* 
60.3 ± 9.6* 
[40–75] 
61.8 ± 6.4* 
[47–80] 
59.7 ± 7.6* 
[44–72] 
Years of Education* 16.6 ± 2.6 * 15.5 ± 5.1* 16.8± 1.6* 
UPDRS* 
2.8 ± 3.0b 
[0–13] 
26.3 ± 15.0 
[7–64] 
32 ± 13.0a 
[13–70] 
*Mean ± standard deviation (SD); age range, years of education range and UPDRS range; a) Mann-
Whitney test (UPDRS): significant difference between Control and PD (p=0.000); b) significant 
difference between (UPDRS) Control and SWEDD (p=0.000). No more significant differences were 
observed. 
 
3.2 Neuroimaging protocols 
The MRI protocols used in this research included T1-w and DTI using a 3T MRI 
scanner (TrioTim, SIEMENS, Erlangen, Germany) and an 8-channel head coil. T1-w 
sequence (3D MP-RAGE) parameters included sagittal plane acquisition; 240 slices; 
repetition time (TR)/echo time (TE)/ inversion time (TI)=2300/2.98/900 ms; flip 
angle=9.0 degrees; matrix=240 x 256; voxel size=1.0 x 1.0 x 1.2 mm3. 
DTI sequence (2D echo-planar imaging) included coronal plane acquisition; 116 
slices; TR/TE=890/88 ms; flip angle=90 degrees; 64 gradient directions; b=0, 1000 
s/mm2; matrix=1044 x 1044; voxel size=2 x 2 x 2 mm3. 
 
3.3 MIBCA Toolbox 
The MIBCA Toolbox is an application designed in MATLAB.(39,40) It is an 
automated all-in-one connectivity analysis toolbox.(39,40) Usable raw data consist of 
anatomical magnetic resonance imaging (aMRI), diffusion magnetic resonance 
(dMRI), functional magnetic resonance (fMRI) and positron emission tomography 
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(PET).(39) The raw data is automatically preprocessed using pipelined software, 
specifically Freesurfer, Diffusion Toolkit, FSL, SPM and Brain Connectivity Toolbox. 
MIBCA processes aMRI from T1-w images, dMRI from DTI, fMRI from blood oxygen 
level dependent on resting state or task-related data and also PET (the last two 
modalities were not used in this study).(39,40)  
The toolbox identifies and processes automatically the different subjects in batches 
and specifically for each modality following a data folder hierarchy.(39)  
In this study only the aMRI and DTI modalities were used. aMRI is the first modality 
to be processed by the MIBCA toolbox (39,40) and is mandatorily required because 
it is used to compute the non-linear transformation that is additionally applied to all 
other modalities.(39) An important step prior to the data preprocessing is the 
conversion of the images (DICOM) into Nifti format.(39,40) The second step (affine 
registration, segmentation, intensity normalization) consists firstly in the registration 
of anatomical images to the Tailarach space using the Freesurfer software,(39,40) 
followed by brain extraction (results were skull-stripping), correction of intensity 
inhomogeneities, segmentation into GM, WM and CSF and normalization of WM 
intensity to 150.(39,40) Other steps are applied such as affine and non-linear 
registration to the Montreal Neurological Institute (MNI) 305 atlas, and parcellation 
into cortical and subcortical ROIs according to the Desikan-Killiany-Tourville atlas (all 
these steps were performed by Freesurfer).(39) In this work, the following were 
usedas imaging metrics: the cortical thickness (CThk), cortical volume (CVol) and 
cortical area (CAr) for cortical ROIs. 
In dMRI, the images are converted (preprocession data) to Nifti format. In the 
conversion process b-values and bvec (gradient vector file) files are generated for 
posterior analysis of the data.(39,40) In the next step, the eddy currents correction is 
adjusted using eddy_correct (available through FSL), and the DTI estimation is 
performed using the dti_recon function (available through Diffusion Toolkit).(39) The 
MD, FA and ADC main eigenvector maps are estimated from cortical and subcortical 
areas.(39,40) To generate the streamlines from diffusion data, deterministic fibre 
tracking was used, which is achieved with the Diffusion Toolkit using the FACT 
algorithm.(39) The generated track is smoothed with the spine_filter of the Diffusion 
Toolkit and loaded into MATLAB.(21,39) The T1-w image was then affine registered 
to the b0 diffusion image, and the transformations applied to the atlas image were 
registered to the T1-w (obtained through the aMRI pipeline).(21,39) Finally, in order 
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to extract the mean MD, FA and fibre count for each ROI, the registered atlas image 
is used.(21,39).  
After the preprocessed and processed approach, intra-modality and inter-modality 
group analysis can be performed. 
In this study, the MIBCA toolbox calculated automatically for each of the studied 
groups (Control, SWEDD and PD) the mean and standard deviation for each 
group.(39) Furthermore, from fibre tracking data, structural connectivity matrices 
were automatically calculated by determining the number of fibres connecting each 
ROI pair (FiberConn).(39) The node degree (Deg), clustering coefficient (ClusC), 
Betweenness centrality (Betw) and Betweenness edge (Edge Betw) metrics were 
calculated using graph theory.(39,40) 
Overall, the matrices and metrics from T1-w data, DTI (imaging metrics) and 
connectivity metrics were estimated for all 96 regions of interest (ROIs). Table 3.2 
summarizes the data processing and analysis implemented in this study.  
 
Table 3.2 – Analysed Modalities and Associated Pre-Processing and Extracted Metrics 
Modality Metrics 
T1 
Cortical thickness (Cthk), cortical volume (Cvol), cortical area 
(CAr) 
DTI Mean diffusivity (MD), fractional anisotropy (FA) 
Connectivity 
metrics 
Node degree (Deg), clustering coefficient (ClusC), 
betweenness centrality (Betw), fibre count (FiberConn), 
betweenness edge (Edge Betw) and distance (Dist) 
 
3.4 Statistical data  
Characterization of subject groups regarding age, gender, years of education and 
Unified Parkinson’s Disease Rating Scale (UPDRS) scores was analysed regarding 
mean, standard deviation, range values and absolute frequency values, when 
appropriate, using IBM’s SPSS. Normality tests were performed to examine whether 
data had normal distributions, including the Kolmogorov-Smirnov and Shapiro-Wilk 
tests. Comparison of subjects’ demographic data between groups was achieved 
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using parametric and non-parametric tests (Chi-square, Student T or Mann-Whitney 
U tests as appropriate). 
Directly by using MIBCA, statistical differences were calculated between two groups 
for each imaging and connectivity metric. A p < 0.05 (2-tailed) was chosen as the 
significance value for all tests. 
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4. Results and Discussion 
 
In this section, group demographic characterization will first be exposed and 
discussed. Further, imaging and connectivity results will be presented and analysed. 
 
4.1 Group Characterization  
Firstly, the descriptive results were explored involving the variables age, years of 
education and UPDRS, followed by Shapiro-Wilk and Kolmogorov-Smirnov tests to 
check the normality of distribution of the variables cited before with a p < 0.05 (2-
tailed) (Table 4.1).  
Age was observed to have a normal distribution since the p-value was higher than 
the significance used in this research. On the other hand, years of education and 
UPDRS showed a lower p-value than the significance, so these variables did not 
have normal distributions. 
With regard to the variations in UPDRS scores of each subject by case, significant 
differences were found between the Control group and the other two groups of study 
(Figure 4.1). The UPDRS scores were observed to be increased in the PD group 
compared to the Control. 
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Table 4.1 – Kolmogorov-Smirnov and Shapiro-Wilk Normality tests 
 
 
Case 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistics N* 
Sig. 
(p-
value) 
Statistics N* 
Sig. 
(p-value) 
Age 
CONTROL 0.082 30 0.200 0.958 30 0.276 
SWEDD 0.131 29 0.197 0.956 29 0.239 
PD 0.120 29 0.200 0.958 29 0.282 
YrsEdu* 
 
CONTROL 0.209 30 0.002 0.952 30 0.195 
SWEDD 0.106 29 0.200 0.941 29 0.095 
PD 0.270 29 0.000 0.860 29 0.001 
UPDRS 
CONTROL 0.269 30 0.000 0.797 30 0.000 
SWEDD 0.182 29 0.012 0.904 29 0.011 
PD 0.100 29 0.200* 0.953 29 0.207 
*N: Number of subjects; Age in years old; YrsEdu = Years of Education; UPDRS = Unified Parkinson’s 
Disease Rating Scale; Sig= Significance. 
 
Figure 4.1 – Box plots displaying significant variations of distribution between the Control (0), SWEDD 
(1) and PD (2) groups, concerning UPDRS scores of each subject.
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Significant differences were also found (Tables 4.2 and 4.3) regarding the UPDRS 
data (Mann-Whitney U test) between the Control and PD groups (p = 0.000), and 
Control and SWEDD groups (p = 0.000) (Table 6). These results are in line with the 
literature.(21,22) No differences between SWEDD and PD were found. This was to 
be expected since the differences in clinical findings and neuropsychological tests 
are very subtle or non-existent, rendering diagnosis of both diseases very 
difficult.(33,41) 
The statistical tests were performed to the three groups: age (Student T-test; p = 
0.548), gender (Chi-square test; p = 0.563) and Years of Education (Kruskal-Wallis 
test, p = 0.472). Those results imply that differences between groups that may be 
found in subsequent analysis should be related to the pathology or to another 
variable not considered. 
To understand whether differences existed between the groups (variable age) of 
Control, SWEDD and PD subjects, an ANOVA test was performed and no significant 
differences were found between the groups (p = 0.635). 
Table 4.2 – Mann-Whitney test 
Case UPDRS 
Control vs SWEDD p = 0.000 
PD vs CONTROL p = 0.000 
 
Table 4.3 – Kruskal-Wallis test 
Control_SWEDD_PD UPDRS 
CONTROL 
p = 0.000 SWEDD 
PD 
 
4.2 Analysis of Imaging and Connectivity metrics 
Normally, the dopaminergic neurons, responsible for neurotransmission, and the 
damage to major pathways are followed by a reduction of dopamine levels in the 
caudate nucleus and putamen in PD.(33,41) As mentioned previously, these 
neurons innervate the basal ganglia, in terms of the dorsal striatum (caudate nucleus 
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and putamen), central striatum (nucleus accumbens and olfactory tubercule), 
substantia nigra, globus pallidus, ventral pallidum and subthalamic nucleus. In 
addition, many studies referred to other structures that are usually damaged, such as 
the hypothalamus, thalamus, motor cortex, prefrontal cortex (orbitofrontal cortex), 
oculomotor nuclei and other structures (temporal, parietal, occipital lobes and 
cerebellum).(33,36,41) The five major pathways in the brain connecting other brain 
regions with the basal ganglia affected in PD are: motor, oculomotor, associative, 
limbic and orbitofrontal circuits.(36) 
In this section, connectograms were made, analysed and compared to each of the 
96 anatomic regions of the brain with the respective imaging and connectivity metrics 
changes. Finally, the results were compared to previous studies. 
As previously stated in the Material and Methods section, the imaging metrics 
analysed were CThk, CAr, CVol, FA and MD, and lastly, the connectivity metrics 
were ClusC, Deg, Betw and Edge Betw. 
In Table 4.4, the acronyms for each T1-w, DTI, connectivity metric and brain 
anatomical region used in this work, as well as their designations, are described. 
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Table 4.4 –The acronyms and designations for all metrics and brain anatomic regions 
Acronyms Designations 
CThk Cortical thickness 
CAr Cortical area 
CVol Cortical volume 
FA Fractional anisotropy 
MD Mean diffusivity 
ClustC Cluster Coefficient 
Deg Node degree 
Betweenness centrality Betw 
FiberConn Number of fibres connecting pair areas 
Dist Distance matrix 
Edge Betweenness Edge Betw 
Rh Right hemisphere 
Lh Left hemisphere 
C Cortex (suffix) 
L Lobule (suffix) 
G Gyrus (suffix) 
FP Frontal pole 
ITG Inferior parietal 
MTG Middle temporal 
STG Superior temporal 
TTG Transverse temporal 
SMG Supra marginal 
SPL Superior parietal 
IPL Inferior parietal 
LG Lingual 
FG Fusiform 
TP Temporal pole 
MeOFC Medial orbitofrontal 
rMFG Rostral middle frontal 
SFG Superior frontal 
LOFG Lateral orbitofrontal 
LOG Lateral occipital 
iCG Isthmus of the cingulate 
Brain Connectivity Analysis of Parkinson's Disease Patients. 
42 
 
caCG Caudal anterior cingulate 
raCG Rostral anterior cingulate 
pCG Posterior cingulate 
caMFG Caudal middle frontal 
PHG Parahippocampal 
ParsO Pars orbitalis 
ParsT Pars triangularis 
ParsOp Pars opercularis 
PCal Pericalcarine 
ERC Entorhinal 
Hip Hippocampus 
Acc Nucleus accumbens 
Cd Caudate 
CC Corpus Callosum 
CCp Corpus Callosum posterior 
CCmp Corpus callossum mid posterior 
CCc Corpus callossum central 
CCma Corpus callossum mid anterior 
CCa Corpus callossum anterior 
Pd Pallidum 
Pt Putamen 
Tha Thalamus 
Amy Amygdala 
Ins Insula 
Cn Cuneus 
PCn Precuneus 
PCG Precentral 
PaCG Paracentral 
PoCG Postcentral 
Bankssts Banks of the superior temporal sulcus 
Cerebll Cerebellum 
  
  
Brain Connectivity Analysis of Parkinson's Disease Patients. 
43 
 
4.2.1 Connectivity Analysis Control vs PD 
In Table 4.5, all significant regional increases and decreases in T1, DTI and 
connectivity metrics were observed. However, the main significant regions with two, 
three and four changes are displayed in bold, underlined and in italic, respectively. 
The analysis was performed taking into account the number of changes in each 
hemisphere.  
In the first comparison (Table 4.5) between Control and PD (Control vs PD), three 
metric alterations were observed on the right hemispherical (Rh) pars triangularis 
(Rh-parsT) regarding an increase in CAr and MD and decrease in FA. This result 
was confirmed in the literature and perhaps can explain the visuospatial deficits and 
the emergence of hallucinations in PD patients.(42)(43) 
In this research, the right nucleus accumbens (Rh-Acc) showed an increase in FA 
and Edge Betw, and a decrease in MD. However, this result contradicts the 
literature. Normally, there is a reduction in FA and an increase in MD.(46,47) This 
controversial finding can possibly be explained by dopamine medication 
administration (this medication can change the real values of metrics).(21,22,33) In 
the left hemisphere (Lh) a decrease of MD and ClusC and an increase of Edge Betw 
was observed in Cerebll Left (L). These results are in line with previous studies and 
may be explained by the damage to dopaminergic neurons (the connections with the 
basal ganglia), and may possibly explain the akinesia/rigidity, tremor gait 
disturbance, dyskinesia and some motor symptoms characteristic of PD.(48,49) 
These results confirm the effects of PD outside the basal ganglia affecting other 
brain regions. 
The brain region with the most metric changes (four or more alterations) was the Lh 
pars orbitalis (parsO) with an increase in Car and MD, and a decrease in FA and 
Betw. The parsO, also known as Brodmann area 47 (inferior frontal gyrus), is 
responsible for several functions, such as language (semantic processing, encoding 
lexical inflection, selective attention to speech and other language functions), 
memory (working memory and episodic long-term memory) and other functions 
(behavioural and motor inhibition, adverse emotional inhibition, smelling familiar 
odours).(50,51) Several studies have demonstrated that apathy resulted from PD. 
This may be due to the damage of dopaminergic neurons within this brain 
area.(50,51) 
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Additionally, decreases in FiberConn (Figure 4.2) in the basal ganglia and corpus 
striatum regions included: Rh-thalamus (Tha), Putamen (Pd) bilaterally and Rh-
Hippocampus (Hip). Lesions on the brain due to PD can affect the dorsal striatum 
and cause involuntary movements or tremors and also lead to symptoms and signs 
suggestive of hypothalamic dysfunction.(34,52) Intriguingly, an increase in fibre 
connections was observed between the Lh-Cuneus (Cn) and the Rh-lateral occipital 
gyrus (LOG), as well as a decrease between the Lh-rostral middle frontal (rMFG) and 
the Rh-frontal pole (FP). These results can possibly be explained by a compensatory 
effect in compensating for the weakness in movement control typically resulting from 
this pathology.(34) 
With regard to the Dist and Edge Betw in Figure 4.2, the differences observed were 
major in the occipital and temporal regions and more minor in Rh-Ins and Rh-ITG, 
respectively. Once again, the occipital and temporal regions can possibly 
compensate for the depression of dopamine levels in neurons.(34) As regards the 
Rh-Ins and Lh-ITG, the reduction of Edge Betw may once again be due to damage 
to dopaminergic neurons and may disturb the limbic region (ITG) and the capacity for 
perception and motor control (usually in PD).(53) 
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Table 4.5 – Statistical values of all metrics obtained with MIBCA software for comparison between 
Control and PD, regarding the T1, DTI and connectivity metrics. Significant values are considered for p 
< 0.05. ∆ is the statistical difference. Red and Blue squares, respectively, represent lower and higher 
values for the second group in comparison to the first. White squares correspond to non-significant 
differences. 
 
CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
FP 
   
Lh:  
∆ = 2.92; 
p = 0.003  
 
Rh:  
∆ = 2.92; 
p = 0.02 
Rh:  
∆ = -2.71; 
p = 0.007 
   
SMG 
       
Rh:  
∆ = -1.97; 
p = 0.049 
LG 
      
Rh:  
∆ = 2.05; 
p = 0.041 
 
FG 
Rh:  
∆ = -1.99; 
p = 0.046 
Lh:  
∆ = -2.14; 
p = 0.032 
      
TP 
 
Lh:  
∆ = -2.63; 
p = 0.008 
      
rMFG 
   
Rh:  
∆ = 3.05; 
p = 0.002 
Lh:  
∆ = -3.10; 
p = 0.002  
 
 Rh:  
∆ = -2.37; 
p = 0.018 
   
SFG 
 
Lh:  
∆ = -1.98; 
p = 0.048   
 
Rh: 
∆ = -1.24; 
p = 0.019 
      
caCG 
Rh:  
∆ = -2.36; 
p = 0.018 
  
Rh:  
∆ = 2.31; 
p = 0.020 
    
pCG 
  
Rh:  
∆ = -2.04; 
p = 0.042 
     
caMFG 
   
Lh: 
 ∆ = 2.52; 
p = 0.011 
    
PHG 
Rh:  
∆ = -1.99; 
p = 0.046 
 
Lh:  
∆ = -2.30; 
p = 0.022 
   
Rh:  
∆ = 2.34; 
p = 0.019 
 
ParsO 
 
Lh:  
∆ = -2.40; 
p = 0.016 
 
Lh:  
∆ = 2.31; 
p = 0.020  
 
 Rh:  
∆ = 2.31; 
p = 0.005 
Lh:  
∆ = -1.99; 
p = 0.046 
  
Lh:  
∆ = 2.03; 
p = 0.042 
ParsT 
 
Rh:  
∆= -2.14; 
p =0.032 
 
Lh:  
∆ = 2.77; 
p = 0.005   
 
Rh:  
∆ = 3.80; 
p = 1.00e-04 
Lh:  
∆ = -2.58; 
p = 0.009   
 
Rh:  
∆ = -2.36; 
p = 0.02 
   
ParsOp 
   
Lh:  
∆= 2.19; 
p =0.028 
    
ERC 
Lh:  
∆ = -1.96; 
p = 0.049 
Rh:  
∆ = -2.16; 
p = 0.031 
 
Rh:  
∆ = 2.22; 
p = 0.026 
    
Acc 
   
Rh:  
∆ = -2.16; 
p = 0.031 
Rh:  
∆ = 2.28; 
p = 0.022 
 
   
CCp 
 
 
 
 
 
∆ = -3.22; 
p = 0.001     
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CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
CCmp 
   
 
 
∆ = 2.52; 
p = 0.011    
CCc 
    
∆ = 2.68; 
p = 0.007    
Pd 
    
L:  
∆ = 2.78; 
p = 0.005 
   
Ins 
 
Lh:  
∆ = -2.02; 
p = 0.043 
Rh: 
 ∆ = -2.04; 
p = 0.041 
     
Cn 
 
Rh: 
 ∆ = -2.58; 
p = 0.009 
      
PCn 
 
Rh:  
∆ = -2.02; 
p = 0.043 
      
PCG 
      
Rh: 
 ∆ = -2.48; 
p = 0.013 
 
CerebLL 
    
L:  
∆ = 1.96; 
p = 0.04   
 
R:  
∆ = 2.33; 
p = 0.019 
L:  
∆ = 2.07; 
p = 0.038 
 
L:  
∆ = -2.27; 
p = 0.023 
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Figure 4.2 – 3D graphs of distance matrix (superior left side), Edge Betweenness (superior right side) 
and FiberConn (below) of Control vs PD test. Significant values are considered when they were p < 
0.05. Red and Blue lines, respectively, represent lower and higher values for the second group in 
comparison to the first. 
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4.2.2 Connectivity Control vs SWEDD 
While there have been many studies using the DWI and DTI techniques in the 
diagnosis of PD, they have almost entirely made a comparison between healthy 
individuals and PD patients. As regards SWEDD studies based on brain connectivity 
and graph theory, they have not, to the best of our knowledge, been published yet. 
The main significant alteration was in the insula of both hemispheres with two metric 
changes, regarding a decrease in MD and increase in ClusC. However, in the Rh-Ins 
an increase in CVol was observed, whilst in the Lh-Ins an increase of FA was 
observed instead. This shows that SWEDD differences probably do not have a 
symmetric manifestation pattern, and curiously, the distance connections in both 
hemispheres decrease. This last result may be due to the damage to dopaminergic 
neurons between the basal ganglia and insular cortex. These metric changes may 
explain, again, the loss of perception and motor control associated with the SWEDD 
condition.(34,53) 
Once again, this test demonstrated that the Cerebll showed connectivity metric 
changes, regarding this time a decrease in Deg. This reinforces again the theory 
previously mentioned regarding the damage to dopaminergic neurons in the 
connections between the basal ganglia and cerebellum.(48,49) 
The FiberConn (Figure 4.3) showed a general increase between the subcortical and 
Rh cortical structures, however the R-Acc, R-Pd and Lh-Tha showed a decreasing 
number of tracts. Interestingly, the Rh-Tha has a different result, presenting an 
increase in the number of connections. This contradictory result can be explained by 
the asymmetrical manifestation patterns of SWEDD. 
With regard to Edge Betw (Figure 4.3), the differences observed were generally 
decreased in all tests, however the parsT showed a marked decrease of its influence 
in this network (decrease in ClusC). As for Dist (Figure 4.3), in this comparison a 
generalized increase was observed, especially in the Rh-parsT, which showed a 
marked increase in its connections with temporal, occipital and basal ganglia 
regions. 
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Table 4.6 – Statistical values of all metrics obtained with MIBCA software for comparison between 
Control and SWEDD, regarding the T1, DTI and connectivity metrics. Significant values are considered 
for p < 0.05. ∆ is the statistical difference. Red and Blue squares, respectively, represent lower and 
higher values for the second group in comparison to the first. White squares correspond to non-
significant differences. 
 
CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
FP 
Rh:  
∆ = 2.10;  
p = 0.036 
 
Rh:  
∆ = 2.60; 
 p = 0.009 
     
ITG 
    
Lh: 
 ∆ = 2.07; 
 p = 0.038 
   
SMG 
   
Lh:  
∆ = -2.62 
p = 0.009 
 
Rh:  
∆ = -2.10 
p = 0.036 
Lh:  
∆ = 2.19;  
p = 0.028  
 
Rh:  
∆ = 2.01;  
p = 0.044 
   
SPL 
 
Lh:  
∆ = -2.34;  
p = 0.019 
 
Lh: 
∆ = -1.99;  
p = 0.046  
 
Rh:  
∆ = -1.99;  
p = 0.048 
    
LG 
    
Rh:  
∆ = 2.39;  
p = 0.017 
 
 
 
 
 
Rh:  
∆ = -2.07;  
p = 0.038 
MeOFC 
    
Rh:  
∆ = 2.19;  
p = 0.029 
 
 
 
 
  
rMFG 
     
 
 
 
 
Lh:  
∆ = -2.28;  
p = 0.022 
 
SFG 
   
 
 
 
 
 
Lh:  
∆ = -2.42; 
 p =0.016 
  
iCG 
   
Lh:  
∆ = -2.60;  
p = 0.009 
 
Rh: 
 ∆ = -2.33; 
p = 0.020 
Lh:  
∆ = 3.01;  
p = 0.048 
   
raCG 
   
 
 
 
  
Lh:  
∆ = -1.99; 
p = 0.047 
 
ParsO 
Lh:  
∆ = 2.10;  
p = 0.036 
Lh:  
∆ = -2.30;  
p = 0.022 
 
 
 
 
Rh: 
 ∆ = 1.06;  
p = 0.049 
   
CCp 
    
∆ = 1.99;  
p = 0.049    
Pd 
   
 
 
 
L: 
 ∆ = 1.51;  
p =0.041  
 
R:  
∆ = 2.39;;; 
p =0.017 
   
Ins 
  
Rh:  
∆ = -2.34;  
p = 0.019 
Lh: 
 ∆ = -1.98; 
p = 0.048 
Lh:  
∆ = 2.27;  
p =0.023  
 
Rh:  
∆ = 2.62;  
p = 0.009 
Lh:  
∆ = -2.08;  
p = 0.037 
 
 Rh:  
∆ = -2.28; 
p = 0.012 
 
 
 
 
 
PCn 
     
Rh:  
∆ = -2.24; 
 p = 0.025 
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 CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
PaCG 
   
Lh:  
∆ = 2.86;  
p = 0.004 
    
PoCG 
   
Lh:  
∆ = -3.20; 
p =0.018 
 
Rh:  
∆ = -2.37;  
p = 0.001 
   
Rh:  
∆ = -2.06; 
 p = 0.039 
Bankssts 
   
Lh:  
∆ = -2.51; 
p = 0.001 
Lh:  
∆ = 2.13;  
p = 0.033 
   
Cerebll 
    
R:  
∆ = 1.96;  
p = 0.049 
 
R:  
∆ = 2.21;  
p = 0.027 
 
 
 
Figure 4.3 – 3D graphs of distance matrix (superior left side), Edge Betweenness (superior right side) 
and FiberConn (below) of Control vs SWEDD test. Significant values are considered when they were p 
< 0.05. Red and Blue lines, respectively, represent lower and higher values for the second group in 
comparison to the first.  
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4.2.3 Connectivity SWEDD vs PD 
The last two groups compared were SWEDD and PD (SWEDD vs PD). In this 
comparison (Table 4.7) the differences between these groups were observed to be 
more extensive than in the other comparisons. In particular, additional changes were 
observed in the temporal lobe regions and frontal lobe regions, regarding Brodmann 
44, 45 and 47 areas bilaterally (pars opercularis, pars triangularis and 
orbitalis).(34,53) It is also important to mention that Brodmann 44 and 45 include 
Broca area (the major function of this area is language processing).(48,53) PD 
normally affects this area and causes speech difficulties, such as a soft, monotone 
voice, slowed hesitant speech or rapid stuttering speech.(50,51) 
The Ins (Brodmann area 33) in both hemispheres presented connectivity changes in 
terms of a decrease in FA and increase in MD.  
Further, the parahippocampal gyrus (PHG) bilaterally showed significant changes, 
concerning CVol, an increase in MD and decrease in FA. A lack of dopamine 
(stimulation) or denervation of PHG can cause atrophy of this region and furthermore 
memory impairment.(50,53) Additionally, these judgements can show the 
predisposition of the salience network in PD and its potential role in memory and 
executive dysfunction.(53) 
Another region with significant metric alterations was Rh-rMFG, with an increase in 
cortical thickness (CThk) and CVol, and a decrease in FA (in both hemispheres). 
The alterations in this region were mentioned before along with the nigrostriatal 
dopaminergic damage.(51,53)  
Moreover, the Rh banks of the superior temporal sulcus (bankssts) demonstrated an 
increase in MD and decrease in FA (bilaterally) and Betw. The bankssts presents 
multisensory processing capabilities, and with these findings, the lack of dopamine in 
this region can likely result in the deterioration of visuoperceptive integration.(54) 
The FP was the region that presented most connectivity changes in this comparison, 
in terms of an increase in CThk and CVol and a decrease in FA (in both 
hemispheres) and Deg. The presence of this finding in this lobe may have several 
explanations. As mentioned previously, decreases of FA values in the frontal lobe 
and other structures are in line with the literature (the changes may occur outside the 
SN and in the rest of the basal ganglia),(34,53) resulting from the damage to 
dopaminergic neurons. Second, diffusion changes may be reflective of frontal lobe 
dysfunction in PD.(42) Many fMRI studies have shown alterations in activation in 
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motor and premotor areas in PD during the performance of motor tasks, particularly 
in the supplementary motor area.(34,53) Dysfunction of the frontal lobe, which 
probably derives from alterations in basal ganglia connections due to nigrostriatal 
dopaminergic damage, plays a role in impaired motor performance resulting in 
hypokinesia.(53) This finding is supported by brain imaging studies (such as 
conventional MRI, fMRI and PET) showing reduced local blood flow in the 
supplementary motor area and the prefrontal region.(9,50) Morphologic longitudinal 
imaging studies have revealed significant brain volume loss in patients with PD 
without dementia compared with healthy patients.(50,51) Frontal lobe alterations 
were found in patients with PD with early cognitive impairment and those with or 
without dementia. However, frontal lobe atrophy, which can occur with the duration 
of the disease, has been described in the late stage of PD. The results of this study 
complement these other studies in demonstrating that diffusion metric changes can 
occur in the frontal lobe in patients with PD (52,53). (However, atrophy was not 
found in the FP in this comparison and in Control-PD, except in Control-SWEDD 
comparison.)  
Once again, Lh-Cerebll presented connectivity metric changes, such as an increase 
in Deg and decrease in ClusC. 
Interestingly, both hemispheres showed marked decrease in the number of fibre 
connections (Figure 4.4), especially Rh-Hip. With regard to the Dist, a high and 
marked decrease was observed (Figure 4.4) for intra- and interhemispheric areas in 
the whole brain. Reductions of intrahemispheric and augmentation of 
interhemispheric Edge Betw were also observed (Figure 4.4). Both findings can 
perhaps show the state of deterioration of PD compared to SWEDD, demonstrating 
the potential of this methodology for differentiating between these two 
neuropathologies.  
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Table 2.7 – Statistical values of all metrics obtained with MIBCA software for comparison between 
SWEDD and PD, regarding the T1, DTI and connectivity metrics. Significant values are considered for p 
< 0.05. ∆ is the statistical difference. Red and Blue squares, respectively, represent lower and higher 
values for the second group in comparison to the first. White squares correspond to non-significant 
differences. 
  CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
FP 
Lh:  
∆ = -2.13; 
p = 0.032 
 
Rh: 
∆ = -2.99; 
p = 0.003 
  
Lh: 
 ∆ = -2.29; 
p = 0.022 
 
Rh: 
∆ = -3.40; 
p = 6.78e-
04 
      
Lh:  
∆ = 2.18; 
p = 0.030 
  
ITG     
Lh:  
∆ = -2.45; 
p = 0.014  
 
Rh:  
∆ = -2.01; 
p = 0.044 
Rh:  
∆ = 2.25; 
p = 0.024 
        
MTG   
Rh:  
∆ = -2.32; 
p = 0.020 
  
 
 
 
  
        
STG       
Lh:  
∆ = 2.27; 
p = 0.023 
        
TTG       
Lh:  
∆ = 2.02; 
p = 0.043 
    
Lh:  
∆ = 1.99; 
p = 0.047 
  
SMG       
Lh:  
∆ = 2.64; 
p = 0.008  
  
Rh:  
∆ = 2.16; 
p = 0.031 
        
SPL       
Rh: 
∆ =2.86; 
p =0.004 
 
 
 
  
Lh:  
∆ = -2.71; 
p = 0.007  
Lh: 
 ∆ = 2.53; 
p = 0.011  
  
IPL       
  
 
 
      
Lh:  
∆ = 2.68; 
p = 0.007 
LG       
  
 
 
    
Rh:  
∆ = 2.17; 
p = 0.030 
  
FG   
Lh:  
∆ = -2.14; 
p = 0.032 
  
  
 
 
        
MeOFC       
  
 
 
Rh:  
∆ = -2.47; 
p = 0.013 
      
rMFG 
Rh:  
∆ =-2.03; 
 p = 0.042 
  
Rh:  
∆ = -2.12; 
p = 0.034 
Lh:  
∆ = 3.47; 
p = 5.24e-
04   
 
Rh:  
∆ = 2.61; 
p = 0.009 
    
Lh:  
∆ = 3.04; 
p = 0.002 
  
SFG     
Lh:  
∆ = -2.00; 
p =0.046   
 
Rh:  
∆ = -2.46; 
p = 0.014 
Lh:  
∆ = 2.86; 
p = 0.004  
  
  
  
LOFG       
Rh: 
 ∆ = 2.85; 
p = 0.004 
Rh: 
 ∆ = -2.04; 
p = 0.042 
  
Lh:  
∆ = 3.32; 
p = 9.06e-
04   
 
Rh:  
∆ = 2.11; 
p = 0.035 
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 CThk (mm) Car (mm2) Cvol (mm3) FA MD ClustC Deg Betw 
LOG       
 
 
 
  
  
 
Rh:  
∆ = 2.01; 
p = 0.044 
  
iCG   
Rh: 
 ∆ = -2.25; 
p = 0.025 
  
Lh:  
∆ = 2.16; 
p = 0.031 
Rh:  
∆ = -2.10; 
p = 0.036 
      
pCG           
Rh:  
∆ = 2.11; 
p = 0.034 
    
PHG     
Lh:  
∆ = -2.15; 
p = 0.031   
 
Rh:  
∆ = -2.25; 
p = 0.025 
Lh:  
∆ = 2.61; 
p = 0.009   
 
Rh:  
∆ = 3.34; 
p = 8.27e-
05 
Lh:  
∆ = -2.21; 
p = 0.027   
 
Rh:  
∆ = -2.78; 
p = 0.005 
      
ParsO       
Lh:  
∆ = 3.23; 
p = 0.001  
 
 Rh:  
∆ = 3.98; 
p = 6.86e-
05 
Lh:  
∆ = -2.67; 
p = 0.008  
 
 Rh:  
∆ = -2.64; 
p = 0.008 
  
Lh:  
∆ = 2.16; 
p = 0.031 
Lh:  
∆ = 2.77; 
p = 0.006 
ParsT       
Lh: 
∆ = 2.46; 
p = 0.014   
 
Rh:  
∆ = 3.42; 
p = 6.23e-
04 
Lh:  
∆ = -2.30; 
p = 0.021 
      
ParsOp       
Lh:  
∆ = 2.32; 
p = 0.021  
 
 Rh:  
∆ = 2.49; 
p = 0.013 
        
ERC       
Rh: 
 ∆ = 2.95; 
p = 0.003 
Rh: 
 ∆ = -2.57; 
p = 0.010 
      
CCp             
∆ = 2.16; 
p = 0.031 
  
Ins       
Lh:  
∆ = 3.02; 
p =0.003  
 Rh:  
∆ = 2.78; 
p = 0.005 
Lh: 
 ∆ = -2.11; 
p = 0.034  
Rh:  
∆ = -2.39; 
p = 0.017 
      
Cn   
Rh:  
∆ = -2.15; 
p = 0.025 
  
Rh:  
∆ = 2.02; 
p = 0.043 
        
PCn   
Rh:  
∆ = -2.15; 
p = 0.031 
            
PCG       
Lh:  
∆ = 2.66; 
p = 0.008   
 
Rh:  
∆ = 2.07; 
p = 0.049 
        
PoCG       
Lh:  
∆ = 2.39; 
p = 0.017   
 
Rh:  
∆ = 2.97; 
p = 0.003 
        
Bankssts       
Lh:  
∆ = 2.66; 
p = 0.008   
 
Rh:  
∆ = 2.88; 
p = 0.004 
      
Rh:  
∆ = 2.16; 
p =0.031 
Cerebll           
L: 
 ∆ = 2.46; 
p =0.014 
L:  
∆ = -2.04; 
p =0.041 
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Figure 4.4 – 3D graphs of distance matrix (superior left side), Edge Betweenness (superior right side) 
and FiberConn (below) of SWEDD vs PD test. Significant values are considered when they were p < 
0.05. Red and Blue lines, respectively, represent lower and higher values for the second group in 
comparison to the first. 
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4.2.4 Overall Connectivity changes 
The obtained results are in line with the literature (21,22,24,32) and also contribute 
to novel knowledge, which should be explored in future studies regarding SWEDD 
and PD differences. All comparisons performed in this research demonstrated 
several and sometimes highly marked changes in all kinds of metrics.  
The biggest changes were observed in Control vs PD and SWEDD vs PD, whereas 
between Control and SWEDD changes also existed, but were not so manifest. In 
Control vs PD patients changes were observed in several metrics, such as a general 
and marked increase of the CAr mostly in frontal, temporal regions. This comparison 
demonstrated as well a substantial decrease of the FA and increase of the MD in the 
whole brain, especially in frontal, temporal and parietal regions. With regard to other 
metrics, such as FiberConn, Dist and Edge Betw, this comparison revealed 
numerous decreases in frontal and temporal regions.  
As for the SWEDD vs PD comparison, several changes were seen in all metrics, 
however the most significant change occurred in connectivity metrics, such as in FA, 
MD, Deg and Dist. Several obvious FA decreases and MD increases were reported, 
affecting the whole brain. Otherwise, decreases of Deg in frontal, temporal and 
occipital regions were noticed as well; decreases of fibre connectivity and Edge 
Betw, especially in basal ganglia and temporal regions, were also noted; and finally, 
a marked decrease of the Dist in frontal and temporal regions was observed. 
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5. Limitations and future perspectives  
This study, just like other researches, is not without limitations. Firstly, the possible 
confounding effects of dopaminergic treatments are not considered in our work. To 
be prudent, future studies are encouraged to take into account the effects of this 
medication on brain connections. Additionally, probabilistic algorithms were not used. 
These algorithms have advantages compared to the deterministic methods, given 
the error associated with each preferential direction of diffusion. Thirdly, the size of 
the sample was a clear limitation of this study. It would be desirable to carry out a 
study with a larger number of individuals to confirm the results obtained in this kind 
of study. 
The automatisms of MIBCA (BCT and FSL) software used to calculate the matrices 
and possible errors in the alignment of images caused by the geometric distortions 
observed in diffusion images, related to the heterogeneities of the external magnetic 
field B0 present during the acquisition of the MRI, can be mentioned as one of the 
possible causes of discrepancies in some of the least expected results, such as the 
nucleus accumbens showing decreased MD, and increased FA, FiberConn and 
Edge Betw, which are not to be expected at all, according to the literature. However, 
in this thesis the same methodology was always used in the calculation of 
connectivity metrics, making this a positive perspective. In future studies this is a 
factor to consider and improve, with the intention of reducing the effect of the 
apparent geometric distortions in diffusion-weighted imaging due to magnetic 
susceptibility differences. It is suggested that in order to alleviate this problem, the 
images can be acquired with different phase encodings and an improvement in the 
correction of geometric distortions. 
Regarding the p-value used as reference for the statistical tests (fixed at 0.05) was 
not Bonferroni corrected. As justification, it was considered that this correction is 
extremely conservative and it was impossible to exclude the dependence of 
variables, which could result in a large number of false negatives as well.  
It is essential to refer as well to the threshold value used to produce matrices of 
adjacency, which have a great influence on the values of connectivity metrics. This 
choice turns out to be greatly influenced by the investigator who leads the 
investigation, based on educated guesses on setting the threshold, although there 
are some publications on the use of graph theory in which the threshold value is 
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adjusted to the group in question. In this study the same threshold level of a 
significance level of 5% was always used. 
Future studies can be considered using other score values in addition to the UPDRS, 
such as the Mini-Mental State Examination to search for possible cognitive 
problems, and the Hamilton Rating Scale of Depression to understand and evaluate 
depression in patients. Another interesting area is fMRI, allied with genetics data, to 
investigate whether correlations exist and to compare any differences between 
SWEDD and PD patients. 
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6. Conclusion 
Throughout the literature, most scientific studies performed until now were focused 
on functional studies in patients with PD, whereas in this study the focus was on 
structural brain connectivity analysis. 
This study was based on analysis of imaging (cortical and diffusion metrics) and 
connectivity metrics in order to search for structural brain connectivity changes. To 
achieve this purpose, specific software was used and methods were allied with 
careful methodology, in terms of the MIBCA software associated with graph theory.  
Brain structural connectivity analysis with application of graph theory can be a very 
powerful method in research, especially in investigating novel biomarkers of disease. 
This technique enables the acquisition of many connectivity metrics that may 
indicate morphological and functional changes in each region. The main motivation 
for using graph theory as a method of analysis in this work was the relative ease of 
understanding, and the higher degree of generalization and interpretation.  
In the first instance, demographic data such as gender, age, years of education and 
UPDRS scores were compared between groups using parametric or non-parametric 
tests, as appropriate. Differences between groups were also evaluated regarding 
imaging and connectivity metrics, and FiberConn, using MIBCA’s statistical 
functions, and differences were visualized in connectograms and brain graphs. 
Significant differences were found concerning the UPDRS scores between the 
Control and PD groups, and Control and SWEDD groups.  
Furthermore, the application of MIBCA resulted in imaging metrics such as CThk, 
CAr and CVol obtained from T1-w data for all 96 ROIs, as well as mean diffusibility 
(MD), fractional anisotropy (FA) and FiberConn from DTI data. Also, SC matrices 
were computed from FiberConn data, as well as derived connectivity metrics such as 
Deg, ClusC, Betw, Edge Betw and distance. 
In the comparison of Control vs PD, several significant differences were observed 
regarding various imaging and connectivity metrics, particularly in the basal ganglia 
of both hemispheres. In the right hemisphere, the nucleus accumbens showed 
decreased MD and increased FA, FiberConn and Edge Betw. These changes were 
similarly observed for the rostral middle frontal gyrus (rMFG) of both hemispheres. 
Finally, changes were also observed for the connection of basal ganglia structures 
such as the putamen and thalamus. These findings may be related to known 
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degeneration of dopaminergic pathways, including the mesolimbic, mesocortical and 
nigrostriatal pathways in PD. 
Secondly, in the Control vs SWEDD test, the splenium of the corpus callosum 
showed decreased MD and Deg and increased FA and FiberConn. Regions of the 
frontal and parietal lobes showed various connectivity metric changes, particularly 
the superior marginal gyrus and superior parietal gyrus of both hemispheres and the 
pars orbitalis of the left hemisphere. These results show changes in different regions 
to those observed for PD, supporting the idea that SWEDD is a distinct nosological 
entity, or entities.  
In the last comparison, PD vs SWEDD, various DTI-based imaging and connectivity 
metric changes were observed in the frontal lobe of both hemispheres, particularly in 
the frontal pole, rMFG and superior frontal gyrus, regions of the mesocortical 
pathway. In the limbic lobe, changes were observed in the isthmus of the cingulate 
gyrus and the parahippocampal gyrus of both hemispheres, which may be related to 
memory impairment. In the insular cortex of both hemispheres a decreased FA and 
increased MD and ClusC were observed. These findings could be related to 
cognitive decline, behavioural abnormalities and somatosensory disturbances. 
All results observed in this study are in line with the literature (except Rh-Acc 
findings) regarding observed changes in regions related to the nigrostriatal, 
mesocortical and mesolimbic pathways.  
These findings may suggest that the study of structural connectivity is an important 
method for distinguishing PD from SWEDD. 
Finally, it should be noted that the object of this study resulted in the submission and 
acceptance of an e-poster, which will be presented in May 2016 at the 24th annual 
meeting of the ISMRM (International Society for Magnetic Resonance in Medicine) in 
Singapore, with the name “Scans Without Evidence for Dopaminergic Deficit 
Patients”. 
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Appendix A  
Sample characterization 
Control (0); SWEDD (1) – Scans Without Evidence for Dopaminergic Deficit; PD (2) – Parkinson’s 
Disease; YrsEdu – Years of education in years;  Age – years old; UPDRS – Unified Parkinson's 
Disease Rating Scale; Feminine (0) –; Masculine (1) –. 
Number Patient ID Group Gender  Age YrsEdu UPDRS 
1 3106 0 0 70 13 0 
2 3112 0 0 63 16 0 
3 3114 0 0 64 21 1 
4 3115 0 1 61 16 0 
5 3151 0 1 58 13 2 
6 3157 0 0 64 20 3 
7 3171 0 1 61 16 3 
8 3161 0 1 45 16 8 
9 3165 0 0 59 16 3 
10 3169 0 1 57 14 5 
11 3191 0 0 66 18 3 
12 3300 0 1 52 18 2 
13 3301 0 1 52 20 1 
14 3310 0 1 65 16 7 
15 3316 0 1 75 22 2 
16 3320 0 1 56 20 1 
17 3389 0 1 72 16 3 
18 3390 0 1 66 17 5 
19 3188 0 1 71 18 2 
20 3172 0 1 70 17 3 
21 3554 0 1 75 18 2 
22 3555 0 1 40 11 13 
23 3563 0 1 60 16 2 
24 3569 0 0 40 13 1 
25 3570 0 1 72 18 2 
26 3571 0 1 46 18 1 
27 3572 0 0 58 16 0 
28 3750 0 1 53 17 0 
29 3756 0 1 65 12 8 
30 3759 0 0 54 16 0 
31 3101 1 1 50 23 12 
32 3170 1 0 60 19 11 
33 3183 1 1 64 18 15 
34 3189 1 0 71 18 15 
35 3580 1 0 69 16 45 
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36 3324 1 1 55 20 37 
37 3326 1 1 69 24 12 
38 3550 1 0 51 12 25 
39 3566 1 0 50 16 7 
40 3573 1 1 52 14 47 
41 3580 1 0 69 16 45 
42 3581 1 1 53 14 24 
43 3582 1 0 63 21 27 
44 3751 1 1 53 10 21 
45 3783 1 0 52 19 14 
46 3810 1 1 67 12 24 
47 3820 1 1 77 8 7 
48 3821 1 1 67 8 48 
49 3836 1 0 59 9 49 
50 3860 1 0 47 9 38 
51 3861 1 1 69 9 25 
52 3862 1 1 62 11 46 
53 3865 1 1 77 8 18 
54 4023 1 0 63 24 64 
55 4031 1 0 62 15 26 
56 4036 1 0 50 16 17 
57 4060 1 1 80 19 21 
58 4064 1 1 73 16 15 
59 4066 1 1 61 24 23 
60 4084 1 1 59 17 12 
61 3102 2 1 64 16 36 
62 3105 2 1 69 18 44 
63 3107 2 1 70 16 24 
64 3108 2 0 50 18 29 
65 3111 2 1 65 14 34 
66 3116 2 1 65 18 70 
67 3118 2 1 60 14 26 
68 3119 2 1 64 16 38 
69 3120 2 0 50 18 38 
70 3122 2 1 62 16 25 
71 3123 2 1 69 18 16 
72 3124 2 1 57 16 29 
73 3125 2 1 46 16 28 
74 3126 2 1 64 18 35 
75 3127 2 0 49 16 16 
76 3128 2 0 60 18 25 
77 3129 2 1 56 16 41 
78 3130 2 1 44 18 13 
79 3132 2 1 50 16 27 
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80 3167 2 0 59 14 38 
81 3168 2 0 63 16 42 
82 3173 2 0 62 18 20 
83 3174 2 1 51 18 26 
84 3175 2 0 57 20 17 
85 3176 2 1 62 19 17 
86 3178 2 1 72 18 6 
87 3181 2 0 65 14 32 
88 3182 2 0 55 18 44 
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Appendix B  
Statistical analysis of structural brain connectivity 
Divulges main significant regional increases and decreases in connectivity metrics between the second 
and first groups. Regions with 2, 3 and 4 significant changes are exhibited in bold, underlined, and italic, 
correspondingly. No CAr decreases were observed. 
 
Control-PD Control-SWEDD SWEDD-PD 
CThk 
increase 
Rh-PHG, FG, caCG; 
Lh-ERC 
 Rh-FP, rMFG, 
Lh-FP 
CThk 
decrease 
 Rh-FP; 
Lh-parsO 
 
CAr 
increase 
Rh-SFG, PCn, parsT, 
ERC, Cn; 
Lh-Ins, TP, SFG, parsO, 
FG 
Lh-SPG, parsO Rh-PCn, MTG, iCG, 
Cn; 
Lh-FG 
CVol 
increase 
Rh-Ins, pCG; 
Lh-PHG 
Rh-Ins Rh-FP, SFG, rMFG, 
PHG, ITG; 
Lh-FP, SFG, PHG, 
ITG, 
CVol 
decrease 
 Rh-FP  
FA 
increase 
R-Acc, CCp Rh-SMG, SPG, 
PoCG, iCG; 
Lh-Ins, SMG, 
SPG, PoCG, 
PaCG, iCG, 
Bankssts, R-Pd, 
CCp 
 
FA 
decrease 
Rh-FP, rMFG, parsT, 
parsO, ERC, caCG; Lh-
FP, rMFG, parsT, parsO, 
parsOp, caMCG  
 Rh-Ins, SMG, SPG, 
rMFG, PCG, PoCG, 
parsT, parsO, 
ParsOp, PHG, LOFG, 
IPL, ERC, Cn, 
Bankssts; 
Lh-Ins, TTG, FP, 
SMG, STG, SFG, 
rMFG, PCG, PoCG, 
parsT, parsO, parsOp, 
PHG, iCG, Bankssts 
MD 
increase 
Rh-FP, rMFG, parsT;   Rh-Ins, parsO, PHG, 
MeOFC, LOFG, ICG 
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Lh-rMFG, parsT, parsO 
ERC, Bankssts; 
Lh-Ins,  parsT, parsO, 
PHG, ERC 
MD 
decrease 
R-Acc, R-Cerbll: 
L- Pd, L-Cerbll, CCc, 
CCmpo 
Rh-Ins, SMG, 
parsO, MeOFC, 
LG, iCG; 
Lh-Ins, SMG, 
iCG, ITG, 
Bankssts, L-Pd, 
CCp; 
R-Pd, R-Cerbll 
 
ClusC 
increase 
 Rh-Ins, PCn; Lh-
Ins, SFG 
Lh-SPG 
ClusC 
decrease 
L-Cerbll Lh-PCG L-Cerbll, PCG 
Deg 
increase 
 Rh-rMFG, raCG L-Cerbll 
Deg 
decrease 
 R-Cerbll Rh-LG, LOFG, LOG; 
Lh-TTG, FP, SPG, 
rMFG, parsO, CCp 
Betw 
increase 
Rh-SMG, L-Cerbll  
 
Betw 
decrease 
Lh-parsO Rh-Bankssts, 
parsO, IPG 
Rh-Bankssts;  
Lh-parsO, IPL 
FiberConn 
Decrease highlight in 
subcortical regions: 
Between R-Thal and Rh-
FP and rMFG; R-Pt and 
Rh-SFG, R-Hip and Rh-
PCG, Lh-Pt and Lh-
LOFG and Lh-TTG; 
Decrease Highlight in 
connections in cortical 
regions: Rh-PCn, Lh-
LOG, Lh-PaCG, Lh-
SPG, Rh-LOG and Rh-
ITG; 
Lh-Ins, Lh-TP, Lh-
parsO,  Lh-LOFG, Lh-
PCn, Lh-LOF and Lh-
rMFG 
Increase highlight in 
subcortical and Cortical 
regions: R-Caudate, 
Decrease highlight 
in connection in 
Lh-SPG, PoCG, 
Lh-Tha, Rh-Acc 
and Pd. 
Increase highlight: 
Rh-SPG, Rh-
LOFG, Rh-Tha, 
CCp and Lh-
LOFG. 
Bilateral hemisphere 
decreasing. 
Decreasing in 
connections with R-
Hip 
Increasing 
connections between 
L-Acc with another Lh 
structures: Tp, and 
Ins, and increasing 
connections with R 
and L-Cerebll 
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CCp, CCa; Fp, Rh-PCn, 
Rh-parsO, LOG, R-Acc 
and Lh-PHG 
Dist 
General increase of 
distance connections, 
especially in occipital and 
temporal regions 
General decrease 
of distance 
connections in 
both hemispheres 
General increase of 
distance connections, 
regarding subcortical 
regions: L-Cd, L-Hip, 
R-Tha and R-Cerebll 
Edge Betw 
Decrease highlight: Rh-
Ins, 
Lh-ITG 
Increase Highlight: R-Acc 
Decrease 
highlight: Rh-
parsT. 
Decrease highlight: 
Rh-STG, LOFG 
Increase Highlight: R-
Cd, Rh-PCn, PoCG 
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Appendix C 
Statistical differences values of all metrics obtained 
with MIBCA software 
Statistics differences values of all metrics obtained with MIBCA software for the comparison between 
Control vs PD, regarding the T1, DTI and connectivity metrics. Red and Blue squares, respectively 
represent, lower and higher values for the second group in comparison to the first. The brain regions 
that hadn’t presented any results were automatic excluded. 
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0.44-0.48 
 
   
PHG 
Rh: 
 3.16-2.98 
 
Lh: 
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0.47- ; 
Rh:0.49- 
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 0.62-0.60 
 
Rh: 
0.54-0.59 
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CThk 
(mm) 
Car 
(mm2) 
Cvol 
(mm3) 
FA MD ClustC Deg Betw 
PCG 
 
     
Lh: 
24.79-23 
 
Cerebll 
 
   
L: 
2.38e-04-2.51e-
04; 
 
R: 
2.15e-04-2.35e-04 
L: 
26.38-30.00 
 
L: 
264.32-135.76 
 
Statistics differences values of all metrics obtained with MIBCA software for the comparison between 
Control vs SWEDD, regarding the T1, DTI and connectivity metrics. Red and Blue squares, respectively 
represent, lower and higher values for the second group in comparison to the first. The brain regions 
that hadn’t presented any results were automatic excluded. 
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0.47-0.43; 
 
Rh: 
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Cn 
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PCn 
     
Rh: 
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Lh: 
0.50-0.43     
PoCG 
   
Lh: 
0.46-0.41; 
 
Rh: 
0.45-0.40 
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Lh: 
0.48-0.42 
Lh: 
2.50e-04-3.41e-04    
Cerebll 
    
R: 
2.15e-04-3.02e-04  
R: 
16.23-18.10  
 
Statistics differences values of all metrics obtained with MIBCA software for the comparison between 
SWEDD VS PD, regarding the T1, DTI and connectivity metrics. Red and Blue squares, respectively 
represent, lower and higher values for the second group in comparison to the first. The brain regions 
that hadn’t presented any results were automatic excluded. 
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Appendix D 
Control vs PD Connectogram 
 
Connectogram for CONTROL vs PD. Right (Rh) and left (Lh) hemisphere represent the cortical brain 
regions (R-light gray and L darker gray) and the black regions characterises subcortical regions. From 
inner to outer rings the sequence used were: cortical thickness, cortical area, cortical and subcortical 
volumes volume fractional anisotropy, mean diffusivity, clustering coefficient, node degree and 
betweeness centrality. Red and Blue squares, respectively represent, lower and higher values of the 
conforming ring metric for the second group in comparison to the first. In the centre we have the 
structural diffusion tensor imaging connectivity data, where Red and Blue lines, respectively represent, 
decreasing and increasing number of fiber between the groups.  
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Appendix E 
Control vs SWEDD Connectogram 
 
Connectogram for CONTROL-SWEDD. Right (Rh) and left (Lh) hemisphere represent the cortical brain 
regions (R-light gray and L darker gray) and the black regions characterises subcortical regions. From 
inner to outer rings the sequence used were: cortical thickness, cortical area, cortical and subcortical 
volumes volume fractional anisotropy, mean diffusivity, clustering coefficient, node degree and 
betweeness centrality. Red and Blue squares, respectively represent, lower and higher values of the 
conforming ring metric for the second group in comparison to the first. In the centre we have the 
structural diffusion tensor imaging connectivity data, where Red and Blue lines, respectively represent, 
decreasing and increasing number of fiber between the groups.  
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Appendix F 
SWEDD vs PD Connectogram 
 
Connectogram for SWEDD-PD. Right (Rh) and left (Lh) hemisphere represent the cortical brain regions 
(R-light gray and L darker gray) and the black regions characterises subcortical regions. From inner to 
outer rings the sequence used were: cortical thickness, cortical area, cortical and subcortical volumes 
volume fractional anisotropy, mean diffusivity, clustering coefficient, node degree and betweeness 
centrality. Red and Blue squares, respectively represent, lower and higher values of the conforming ring 
metric for the second group in comparison to the first. In the centre we have the structural diffusion 
tensor imaging connectivity data, where Red and Blue lines, respectively represent, decreasing and 
increasing number of fiber between the groups.  
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